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ABSTRACT 
 
Ryan J. Jacoby: A Translational Study of the Mechanisms of Exposure Therapy for Obsessions: 
Gradual vs. Variable Exposure Intensity 
(Under the direction of: Jonathan S. Abramowitz) 
 
Despite the efficacy of exposure and response prevention (ERP) for OCD, patients who 
primarily experience obsessions are at heightened risk of attenuated outcomes and relapse. The 
current study sought to translate laboratory research on inhibitory learning to the use of ERP for 
primary obsessions, with the ultimate aim of maximizing outcome and reducing the need for 
follow-up services for this group of at-risk patients. Although preliminary research suggests that 
learning to tolerate varying levels of fear during exposure therapy enhances long-term outcomes 
for some anxiety-related problems, no previous studies have examined this in the treatment of 
obsessions. In the current study, 30 participants with a moderately distressing obsessional 
thought were randomly assigned either: (a) the gradual exposure condition (EXP-G), 
emphasizing fear reduction, or (b) the variable exposure condition (EXP-V), emphasizing 
variability in exposure intensity (EXP-V). Both groups completed four twice-weekly exposure 
sessions in which subjective and physiological indices of fear were collected. Clinical interview, 
self-report, and behavioral outcome measures were evaluated by an independent assessor at pre-
treatment (PRE), post-treatment (POST), and 1-month follow-up (1MFU). Both the EXP-G and 
EXP-V interventions were associated with significant decreases in interview, self-report, and 
behavioral measures of fear from PRE to POST, with no significant differences in PRE/POST 
changes between the two groups. Furthermore, there was no significant return of fear for either 
  iv 
group from POST to 1MFU. Variability in subjective and physiological fear did not predict 
treatment outcomes, which is in contrast to previous studies suggesting benefits of variability in 
fear level during exposure for other anxiety-related problems. These results indicate that 
random/variable exposure warrants future study to better understand the mechanisms, 
moderators, and implications of this novel approach. 
Key words: Exposure therapy, Obsessive Compulsive Disorder, Fear Hierarchy, 
Variability, Heart Rate, Skin Conductance 
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A TRANSLATIONAL STUDY OF THE MECHANISMS OF EXPOSURE THERAPY 
FOR OBSESSIONS: GRADUAL VS. VARIABLE EXPOSURE INTENSITY 
 
To date, exposure and response prevention (ERP; Abramowitz, 2006; Foa, Yadin, & 
Lichner, 2012) is the most efficacious psychological treatment for obsessive compulsive disorder  
(OCD; Abramowitz, 1996; Eddy, Dutra, Bradley, & Westen, 2004; Foa et al., 2005; Olatunji, 
Davis, Powers, & Smits, 2012) outperforming control treatments (e.g., relaxation) on primary 
OCD symptom measures with a large effect size (Olatunji et al., 2012). Meta-analytic reviews 
conclude that approximately 69% of patients experience a clinically significant improvement in 
OCD symptoms upon completion of a therapeutic course of ERP (Eddy et al., 2004). Despite the 
success of this treatment, however, a substantial percentage of patients (14-31%) are classified as 
non-responders (Foa et al., 2005; Norberg, Calamari, Cohen, & Riemann, 2008). Furthermore, of 
those who respond, up to 50-60% experience at least partial relapse (i.e., significant worsening of 
symptoms at a later follow-up assessment; Craske & Mystkowski, 2006; Eisen et al., 2013; 
Simpson, Franklin, Cheng, Foa, & Liebowitz, 2005). 
Patients who primarily experience obsessions (sometimes referred to as “pure 
obsessionals”) are especially likely to have attenuated outcomes (Alonso et al., 2001; 
Christensen, Hadzi-Pavlovic, Andrews, & Mattick, 1987; Mataix-Cols, Marks, Greist, Kobak, & 
Baer, 2002; Rufer, Fricke, Moritz, Kloss, & Hand, 2006; Williams et al., 2014). Individuals with 
this presentation of OCD often meet criteria for the OC subtype involving unacceptable 
obsessional thoughts, images, urges, or doubts regarding sex, immorality, religiosity, or harm, 
along with subtle mental rituals, neutralizing, reassurance-seeking, and avoidance behavior 
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(Abramowitz, Taylor, & McKay, 2009). Given that absolute certainty can never truly be attained 
about some of these matters (e.g., “Am I a good person?” or “Is God upset with me?”), plus the 
relative ease and frequency with which mental rituals can be enacted (e.g., without the therapists’ 
awareness), these individuals tend to experience heightened daily distress and attenuated 
responses to treatment (Williams et al., 2011; Williams, Mugno, Franklin, & Faber, 2013). Thus, 
enhancing ERP outcomes for this impervious manifestation of OCD represents a strong unmet 
need.  
The majority of clinical research on ERP, including investigations addressing the 
treatment of primary obsessions, has emphasized maximizing treatment outcome in the short-
term (i.e., therapy efficacy); however, investigations aimed at maximizing the long-term 
effectiveness of ERP and reducing patient need for follow-up services (i.e., relapse prevention) 
are necessary. In addition, it is important to not only determine whether ERP is efficacious, but 
also to better understand the mechanisms of change by which patients with obsessions improve, 
as understanding these mechanisms can lead to maximizing the long-term effectiveness of this 
treatment approach.  
Recently, the mechanisms of exposure have been questioned, as researchers (e.g., Craske 
et al., 2008) are contending that the long-standing and widely accepted idea that exposure works 
by breaking conditioned fear responses via habituation (i.e., Emotional Processing Theory, EPT) 
is at odds with laboratory research on fear extinction—the learning process that occurs during 
exposure therapy (Eelen, Hermans, & Baeyens, 2001; Eelen & Vervliet, 2006; Hermans, Craske, 
Mineka, & Lovibond, 2006). Specifically, this research shows that rather than “breaking” fear-
based connections (as was traditionally proposed), exposure therapy leads to the learning of new 
non-threat (i.e., inhibitory) associations that compete with older threat associations. An important 
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aim of exposure therapy, therefore, is to promote the encoding and long-term recall of the newly 
learned non-threat connections so that they inhibit fear-based learning; a process termed 
“inhibitory learning”. The current study, therefore, sought to translate laboratory findings on 
inhibitory learning to exposure therapy for obsessions in order to ultimately improve ERP for 
this especially at-risk group. I will first review the theorized mechanisms of change in ERP by 
discussing the traditional EPT and its limitations, and contrasting this model with laboratory 
research supporting inhibitory learning theory (ILT) approaches to exposure. Next, I will 
summarize research aiming to optimize inhibitory learning and long-term treatment outcome for 
anxiety disorders by maximizing exposure variability (i.e., varying the intensity of exposures). 
Finally, I will describe how the current study aims to extend this work to individuals with 
primary obsessions.  
Theoretical Mechanisms of Change in ERP 
Emotional Processing Theory (EPT). Emotional processing theory (EPT; Foa, Huppert, 
& Cahill, 2006; Foa & Kozak, 1986; Foa & McNally, 1996), has traditionally been the dominant 
theoretical model for explaining improvement during ERP. This theory suggests that in order to 
be effective, exposure must activate a “fear structure” and then “information provided during 
therapy must…be incompatible with the pathological elements in the [fear] structure” (Foa & 
McNally, 1996, p. 332). This incompatible information is theorized to become integrated via 
“corrective learning,” such that non-fear based elements replace (Foa & Kozak, 1986), or 
compete with (Foa et al., 2006; Foa & McNally, 1996), fear based associations. 
According to EPT, habituation of fear (Groves & Thompson, 1970; Lader & Mathews, 
1968; Watts, 1979) is a critical index of change in ERP and has been considered evidence that 
learning is taking place. Habituation is a short-term non-associative sensory effect resulting in 
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one’s “decreased response to repeated stimulation” (Groves & Thompson, 1970, p. 419) such 
that one’s “original reaction towards the stimulus diminishes in intensity or even disappears” 
(Eelen et al., 2001, p. 251). Thus, patients who experience habituation of anxiety are expected to 
respond less fearfully to anxiety-related stimuli over time. There are a variety of ways in which 
habituation can be quantified. Specifically, Lang’s three-systems approach suggests that fear 
reactions are made up of three response symptoms: verbal (i.e., self-report quantification of 
anxiety level using the Subjective Units of Distress scale, SUDS; Wolpe, 1973), behavioral (e.g., 
observable avoidance), and physiological (e.g., heart rate [HR] and skin conductance [SC]).  
Accordingly, therapists operating from an EPT framework use reductions in patient 
distress within and between exposure sessions as indicators of successful treatment outcome. 
Specifically, Foa and colleagues proposed that there are three indicators of emotional processing 
that predict successful outcomes in exposure therapy: (1) initial fear activation (IFA; peak fear 
level during an exposure minus baseline fear level before exposure began), (2) within-session 
habituation (WSH; peak fear level during an exposure minus ending fear level), and (3) between-
session habituation (BSH; peak fear level during an exposure minus peak fear level during the 
subsequent exposure). Foa further suggests that between-session habituation is dependent on 
within-session habitation, and thus is the basis for longer-term learning.  
This focus on habituation has several implications for the traditional delivery of exposure 
therapy for obsessions. First, when providing the rationale for ERP, therapists explain that 
“anxiety does not last forever but instead it decreases over time” (i.e., WSH; Foa et al., 2012, p. 
94) and that “after repeated exposure practice, such situations will no longer make you feel as 
uncomfortable as they once did” (i.e., BSH; Foa et al., 2012, p. 150). Second, therapists 
determine the length of the session based on the time to habituation; specifically, exposures can 
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be terminated once habituation occurs (Foa et al., 2012). Third, therapists take a hierarchical 
approach to planning exposures in order to facilitate BSH, such that treatment begins with 
exposures of moderate intensity (e.g., provoking SUDS in the 40-50 range) and systematically 
progresses up the fear hierarchy until more intense (i.e., anxiety-provoking) exposures are 
accomplished. Thus, the importance of WSH and BSH as indicators of treatment success is 
embedded in: (a) the treatment rationale, (b) the implementation of exposure, and (c) longer-term 
treatment planning. Indeed, therapists are warned that “patients who fail to habituate during 
exposure would be expected to profit little from therapy” (Foa & Kozak, 1986, p. 30).  
Questioning habituation as an indication of learning. Although habituation usually 
occurs during exposure sessions (Grayson, Foa, & Steketee, 1982; Grey, Sartory, & Rachman, 
1979; Parkinson & Rachman, 1980; Sartory, Rachman, & Grey, 1977; Watson, Gaind, & Marks, 
1972), the literature examining habituation as a predictor of exposure therapy outcome is 
overwhelmingly mixed (For a comprehensive review, see Craske et al., 2008). For example, 
although some studies demonstrate that WSH is predictive of better treatment outcome (Foa et 
al., 1983; van Minnen & Hagenaars, 2002), many additional studies have found no relationship 
(Baker et al., 2010; Jaycox, Foa, & Morral, 1998; Kozak, Foa, & Steketee, 1988; Meuret, Seidel, 
Rosenfield, Hofmann, & Rosenfield, 2012). Additionally, one study that examined the inter-
relationship between WSH and BSH found no significant association (Baker et al., 2010), 
challenging EPT’s tenant that WSH is a necessary prerequisite of BSH and thus longer-term 
change. Other studies demonstrate that successful response to exposure can occur in the absence 
of habituation (e.g., Rachman, Craske, Tallman, & Solyom, 1986; Rowe & Craske, 1998; Tsao 
& Craske, 2000). In summary, these investigations suggest that habituation is not necessarily 
evidence of “corrective learning” and is not a reliable predictor of outcome for the treatment of 
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anxiety. Thus, therapists may be over-relying on habituation as an indicator of patient 
improvement since decline in anxiety during exposure may occur, but this decline is not 
necessary for optimal long-term outcome. 
Consequences of over-reliance on habituation. In addition to these findings that 
habituation may be an unreliable predictor of treatment success, over-reliance on fear reduction 
may also have various unintended negative consequences for the lessons patients take from 
exposure therapy (Abramowitz & Arch, 2014). First, emphasizing the importance of habituation 
of anxiety during exposure may foster a continued “fear of fear,” implying that lower levels of 
anxiety are “safer” or “easier to tolerate” than higher levels. This might also amplify anticipatory 
anxiety about items reserved for later in treatment (i.e., at the top of the fear hierarchy). Second, 
if immediate fear-reduction is the primary treatment goal, patients may end up using exposures 
as a means of controlling their anxiety rather than learning that anxiety itself is not threatening 
and can be managed (Craske, Liao, Brown, & Vervliet, 2012). Finally, as a result of over-
reliance on habituation, patients might interpret surges of high anxiety following treatment as a 
sign of failure, meaning that one instance of return of fear may lead to a full relapse 
(Abramowitz & Arch, 2014; Craske et al., 2008). This is particularly problematic in the case of 
treating obsessions since these types of intrusive thoughts are ubiquitous experiences (e.g., 
unwanted thoughts about harm; Abramowitz, 2006) and often intrude abruptly without 
identifiable evoking stimuli (Lee & Kwon, 2003); thus, unexpected surges of anxiety are 
especially likely. Although short-term success often appears to be achieved relying on 
habituation, therefore, these various lessons patients learn when therapists emphasize fear 
reduction may problematically attenuate longer-term retention of treatment gains.  
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The New Theory of Disuse: Fear expression vs. fear learning. In addition to these 
theories that habituation may be a deceptive (and perhaps problematic) index of change, Bjork 
and Bjork’s (1992, 2006) New Theory of Disuse, provides empirical evidence that an emphasis 
on in-session performance (i.e., habituation) is misleading for understanding long-term exposure 
treatment outcome. This work applies lessons from basic research on learning and memory to 
exposure therapy for anxiety disorders. In explaining how humans store and recall information 
from memory, Bjork and Bjork distinguish between retrieval strength and storage strength. First, 
when learned associations are not continually accessed (i.e., with “disuse”), their absolute and 
relative retrieval strength (i.e., the amount of information an individual can access from memory 
at a given moment in time or “performance”) will lessen over time until these associations are no 
longer accessible. This process is adaptive, so that items that are not being actively used are not 
interfering with other items in memory (e.g., the name of your kindergarten teacher when you are 
a senior in college).  
On the other hand, once storage strength is accumulated (i.e., how “entrenched” or 
“inter-associated” items are in memory and thus how well a piece of information has been 
“learned”) it can never be lost, and these associations are readily re-learnable should they 
become important again (i.e., if the original environmental, interpersonal, emotional, or 
situational cues associated with the information are reinstated). Thus, learned associations 
remain in memory even with disuse (i.e., the memories themselves don’t fade; but access to them 
does). Again, this process is adaptive because following a change in context the original learning 
may become applicable again (e.g., if you returned to visit your elementary school). With anxiety 
disorders, however, this persistence of learned associations and fearful responding can be 
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problematic, as the original fear-based associations that remain in memory (even with disuse) 
leave individuals vulnerable to relearning and relapse following exposure therapy.  
Based on these distinctions between retrieval capacity (i.e., performance in the session) 
and storage strength (i.e., long-term learning generalized to real-world contexts), therefore, 
treatment should be designed to optimize storage strength of new non-fearful responding (vs. 
focusing on retrieval strength). However, Bjork and Bjork (2006) argue that exposure therapists 
incorrectly assume that performance during exposure trials (i.e., habituation) is predictive of 
long-term learning. Accordingly, they may favor treatment techniques that facilitate performance 
in the session (e.g., systematic and gradual exposure to foster habituation) versus methods that 
maximize the long term encoding and generalization of storage strength (as described in the 
sections that follow).  
Fear extinction and inhibitory learning theory. In contrast to habituation of fear, 
which is a non-associative process representative of performance during a session, fear 
extinction is a form of associative learning in which patients repeatedly confront fear-eliciting 
stimuli (i.e., conditioned stimulus, CS) in the absence of an aversive unconditioned stimulus 
(US), with the desired result being the reduction of expectancies about the likelihood and 
severity of feared consequences (i.e., one no longer expects the US to follow the CS; Eelen et al., 
2001; Myers & Davis, 2007; Rescorla, 2001; Vansteenwegen, Dirikx, Hermans, Vervliet, & 
Eelen, 2006). The ultimate therapeutic goal is for patients to alter their behavior as a result of 
these new expectancies. For example, consider the case of Cindy who experiences unwanted 
intrusive thoughts and impulses that she may one day stab her spouse with a knife when she is 
cooking. To allay her uncertainty, she engages in mental rituals (e.g., assuring herself “I’m a 
good wife”) and avoids anxiety-provoking triggers (e.g., knives). During fear acquisition, Cindy 
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learned the contingency between knives (i.e., the CS) and experiences of anxiety and uncertainty 
(i.e., the US). During exposure therapy (i.e., extinction), she would practice confronting knives 
and thoughts about stabbing her partner (i.e., the CS) without the US (i.e., she learns that anxiety 
and uncertainty are more tolerable that she thought and that being near knives is not as dangerous 
as she expected). 
A mechanism that has been proposed to explain the process of extinction is inhibitory 
learning theory (ILT; Lang, Craske, & Bjork, 1999; Myers & Davis, 2007; Rescorla, 2001). 
According to ILT, the original excitatory threat (CS-US) association learned during fear 
acquisition is not erased or replaced by the new non-threat (CS-noUS) inhibitory associations 
learned during extinction (i.e., exposure therapy). Rather, the CS becomes an ambiguous 
stimulus with two opposite meanings, which both remain in memory and compete for retrieval 
(e.g., Bouton, 1993; Bouton & King, 1983; Rescorla, 1996, 2001). That these original fear-based 
associations remain is demonstrated by the fact that fear can return following successful 
exposure therapy, which will be discussed in the following section. 
Return of fear. Return of fear (ROF; Rachman, 1979, 1989) refers to “reappearance of 
fear that has undergone partial or complete extinction” (Rachman, 1989, p. 147). When ROF 
occurs, the patient has recovered the original stimulus-response association, and his or her fear 
returns to a higher level than was demonstrated at the end of extinction (for reviews see: Craske 
& Mystkowski, 2006; Hermans et al., 2006; Vervliet, 2008).1 There are three ways in which 
previously extinguished fear responses might reappear.  
                                                 
1Importantly, this concept refers to a heightened response to a single presentation of a stimulus 
(Rachman, 1989), but an instance of ROF can also contribute to a complete clinical relapse in 
which distress and functional impairment result. 
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First, spontaneous recovery, refers to the fact that fear of the CS can return with the 
passage of time in the absence of further training (Baum, 1988; Pavlov, 1927; Quirk, 2002). The 
process of memory regression suggests that when we learn something new (e.g., unwanted 
thoughts of stabbing a loved one are not necessarily dangerous), this newer learning is most 
accessible immediately following the learning process (Bjork & Bjork, 1992). If this newer 
learning is not continually practiced (i.e., with disuse) it becomes less and less accessible, while 
the original fear learning (i.e., unwanted stabbing thoughts are dangerous) becomes progressively 
more accessible (since it was acquired over a longer period of time and has likely generalized to 
multiple contexts). Thus, patients may perform well at the end of treatment, but not maintain 
their gains at a later follow-up assessment.  
Second, context renewal refers to a return of fear as a result of a context change after 
extinction (Bouton, 2002; Bouton & Swartzentruber, 1991; Mystkowski & Mineka, 2007; 
Vansteenwegen et al., 2006). Specifically, when a CS (e.g., knife) is paired with a US (i.e., 
anxiety, uncertainty, fear) in one context during fear acquisition (e.g., the kitchen at home), and 
then is presented alone during extinction in a different context (e.g., the therapy room with the 
therapist), renewal occurs when the CS is encountered either back in the original context or in a 
novel context (e.g., a restaurant; Bouton, 1993; Bouton & Bolles, 1979; Bouton & King, 1983; 
Vansteenwegen et al., 2005). Thus, following extinction the CS has become ambiguous (i.e., it 
predicts both the occurrence and absence of the US), and the meaning retrieved is determined by 
the degree to which the extinction context matches the follow-up context (Bouton & Brooks, 
1993). 
Finally, reinstatement refers to the occasion in which unexpected (i.e., without the CS 
being present) presentations of the aversive US reignite fear of the previously extinguished CS 
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(Bouton & Swartzentruber, 1991; Dirikx, Hermans, Vansteenwegen, Baeyens, & Eelen, 2004, 
2007, Hermans et al., 2005, 2005; Rescorla & Heth, 1975; Vansteenwegen et al., 2006). For 
example, an unexpected surge of anxiety (US) could reinstate fear-based associations and 
expectancies of anxiety such that individuals become once again fearful of confronting OCD-
related cues (CS; e.g., knives).  
 Overall therefore, the fact that original fear-based associations can be uncovered by these 
three processes suggests that fear is not “unlearned.” Thus, a challenge when implementing 
exposure therapy is to maximize the likelihood that the new non-threat associations will inhibit 
the retrieval of the threat associations (Lang et al., 1999). As a result, a new methodology of 
exposure is necessary that optimizes inhibitory learning (rather than emphasizes immediate fear 
reduction) in order to maximize long-term outcome and inoculate patients against later return of 
fear. One important way to maximize inhibitory learning is to vary the intensity of exposures, 
which will be discussed in the following section. 
Optimizing Inhibitory Learning by Maximizing Exposure Variability 
Theorized benefits of variability. Importantly, introducing variability into exposures 
serves to foster “desirable difficulties” (Bjork, 1994). Variation is a “difficulty” because it 
introduces challenges for the patient during exposure (as learning cues and levels of anxious 
arousal shift and change) and slows the rate at which fear declines in the short-term. At the same 
time, this is “desirable” because it results in more durable long-term learning (i.e., retention, 
transfer, and generalization) by introducing elements of surprise and uncertainty that patients 
encounter in real-world settings (Bjork, 1994). Specifically, there are three concrete benefits to 
introducing variability in exposure practice (Bjork & Bjork, 2006).  
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First, greater variability may allow more opportunities for corrective learning to occur. 
The Rescorla-Wagner model (Rescorla & Wagner, 1972; Wagner & Rescorla, 1972) states that 
we learn something new when there is a discrepancy between what we predict is going to happen 
(i.e., our expectancy) and what actually occurs; in other words, when we are “surprised” 
(Rescorla, 1988, p. 153). Based on this theory, when individuals are just beginning exposure 
therapy, the discrepancy between fearful predictions and reality are high (Rescorla & Wagner, 
1972). For example, if Cindy were conducting an exposure to holding a knife while standing 
near her husband and her predictions (i.e., that she won’t be able to handle the anxiety, will “fall 
apart,” and will stab him) do not occur, this surprising experience will violate her expectations 
and a powerful non-threat association will be generated. Over time with repeated exposure, 
however, the level of surprise diminishes as individuals’ expectations are modified. Accordingly, 
introducing elements of variability (i.e., varying exposure intensity and associated fluctuations in 
anxious arousal) maximizes surprise and provides patients with repeated opportunities to learn 
something new about the CS (by disconfirming their expectations as dramatically as possible). 
Second, the more diverse the conditions under which learning takes place, the more 
retrieval cues are generated (i.e., signals that will trigger memories of the extinction learning). 
State-dependent learning (Bouton & Swartzentruber, 1991) suggests that extinction is specific to 
the physiological context, such that individuals who learn and are tested while in congruent 
physiological states (e.g., high anxious arousal) will have better memory of the learning phase 
than individuals who experience a mismatch of internal states (e.g., learning when unaroused and 
testing when highly aroused). These findings have been demonstrated with both anxiolytic (i.e., 
anxiety reducing, e.g., diazepam; Marks, Viswanathan, Lipsedge, & Gardner, 1972) and 
anxiogenic (i.e., anxiety inducing, e.g., caffeine; Mystkowski, Mineka, Vernon, & Zinbarg, 
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2003) substance-induced states. Accordingly, the experience of fluctuating fear during exposure 
therapy allows for a broader variety of emotions and stimuli (e.g., fear, uncertainty, obsessive 
thoughts) to become associated with extinction (Bouton, 2000; Bouton, Woods, & Pineño, 2004) 
so that non-threat associations will be more easily retrievable (Culver, Stoyanova, & Craske, 
2011).  
Finally, these variabilities ultimately promote a generalization of durable corrective 
learning, as patients discover that non-threat associations hold across a variety of emotional 
contexts (Craske et al., 2008, 2012). Indeed, the patient has to engage in higher order learning 
(i.e., analyzing, evaluating, and synthesizing vs. just memorizing or remembering) in order to 
combine information across contexts and develop a common strategy for handling fear cues that 
maximizes performance despite the variation (e.g., Bjork & Bjork, 1992, 2006; Bouton & 
Swartzentruber, 1991; Estes, 1955; Magill & Hall, 1990; Schmidt & Bjork, 1992). Since 
encounters with obsessional stimuli tend to present themselves unexpectedly and randomly in the 
real world, the variation more fittingly prepares patients for experiences following therapy. 
Therefore, in contrast to the lessons patients may take from an exposure framework that 
emphasizes fear reduction and habituation (as described above), from a “desirable difficulty” 
approach (i.e., maximizing variability and optimizing inhibitory learning), patients ideally learn 
that obsessions, anxiety, and uncertainty are opportunities to practice managing and tolerating 
these internal experiences, as opposed to signs of relapse or failure. This approach may serve to 
inoculate patients against ROF. Indeed, whether an unexpected increase in anxiety following 
treatment (i.e., a lapse) leads to a more permanent return of symptoms (i.e., a relapse) may 
depend on the degree to which the patient has learned to tolerate anxiety (i.e., obsessional 
thoughts, and uncertainty) during exposure (Abramowitz & Arch, 2014).  
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As previously mentioned, individuals with obsessions may especially benefit from 
exposures maximizing surprise and variability in order to practice fear tolerance, since these 
types of intrusive thoughts often intrude abruptly without identifiable evoking stimuli (Lee & 
Kwon, 2003). Furthermore, individuals with the unacceptable thoughts dimension of OCD (i.e., 
obsessing and mental neutralizing) tend to demonstrate high levels of intolerance of uncertainty 
(IU; Abramowitz & Deacon, 2006; Holaway, Heimberg, & Coles, 2006; Jacoby, Fabricant, 
Leonard, Riemann, & Abramowitz, 2013; Tolin, Brady, & Hannan, 2008). IU refers to “beliefs 
about the necessity of being certain … and about adequate functioning in situations which are 
inherently ambiguous” (Obsessive Compulsive Cognitions Working Group, 1997, p. 678). 
Individuals who are high in IU have a lower perceptual threshold of ambiguity, find uncertainty 
to be distressing, believe that uncertainty is negative, think it should be avoided, and have 
difficulty functioning in uncertain or ambiguous situations (Buhr & Dugas, 2002; Krohne, 1993). 
Given the ubiquity of ambiguity and uncertainty in everyday life, individuals high in IU tend to 
experience heightened daily distress. Thus, it may be that individuals with obsessions would 
particularly benefit from interventions that maximize variability and uncertainty during exposure. 
Variability of fear responding predicts treatment outcome. In support of these 
theories about the benefits of variability for long-term learning, research examining mechanisms 
of change during treatment indicates that variability of fear responding during exposure predicts 
superior long-term outcomes. Specifically, in samples fearful of public speaking (Culver, 
Stoyanova, & Craske, 2012) and contamination (Kircanski et al., 2012), variability in subjective 
fear (i.e., the standard deviation of SUDS ratings across exposures) predicted lower self-reported 
fear at follow-up testing. These finding suggest that individuals who learned to tolerate varying 
levels of anxious arousal during treatment experienced reduced fearful responding long-term. 
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Experimentally manipulating exposure intensity to optimize variability. Based on 
these findings, a few studies have sought to determine whether conducting exposures in a 
random and variable order can experimentally induce physiological variability and optimize 
long-term gains. As previously mentioned, exposures are typically conducted in a gradual (i.e., 
hierarchical) manner in clinical settings. Specifically, potential exposure tasks are rank-ordered 
according to predicted SUDS levels, and then treatment progresses by systematically working up 
the fear hierarchy. However, as previously discussed, there are pitfalls to this approach due to 
problematic over-reliance on habituation and perpetuation of “fear of fear” in patients. Therefore, 
instead of structuring exposures in a systematic and gradual way (i.e., to foster habituation), 
patients may maximally benefit from exposure designs in which random and variable practice is 
emphasized in order to purposely provoke physiological variability. 
Indeed, preliminary research suggests that varying the intensity of exposures (and 
associated anxious arousal) enhances long-term outcomes relative to taking a gradual 
hierarchical approach for some anxiety-related problems. First, in a sample of individuals with 
fears of spiders, Rowe and Craske (1998) compared “constant-stimulus” exposure (in which all 
exposure trials were conducted with the same spider) versus “varied-stimulus” exposure using 
four different spiders of varying “shape, color, hairiness, quickness, and size” (p. 723). As 
hypothesized, individuals who received varied-stimulus exposures experienced less habituation 
of anxiety during the exposure trials (i.e., demonstrated worse performance) relative to the 
constant-stimulus exposure group, due to the fact that the exposure stimuli were constantly 
changing. But when both groups were presented with a familiar spider at 3-week follow-up (i.e., 
a spider both groups had previously seen at pre and post-assessments), the variable-stimulus 
group displayed less return of fear (i.e., improved performance) than the constant-stimulus 
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exposure group; thus, the varied-stimulus group benefited in the long-term from the “continual 
readjustment to varying stimulus information” (p. 732). Surprisingly, however, the groups did 
not differ in response to a novel spider at follow-up, which was contrary to hypotheses that 
individuals receiving varied-stimulus exposure would demonstrate generalization of non-threat 
learning to new stimuli and display less ROF in response to this novel spider compared to the 
constant-stimulus group. 
The second study comparing random/variable to gradual exposure was conducted in a 
sample of individuals with fears of heights. The “gradual” exposure group systematically 
progressed up the floors of a tall building (i.e., exposure on the 2nd, 3rd, 4th floors, etc.) 
consistently approaching the balcony in the same manner. The “random and variable” group, 
however, practiced exposures to heights in a random order (e.g., 7th floor, 2nd floor, 5th floor, 10th 
floor, etc.) and approached the balcony in a different style at each trial (e.g., leaning on the 
railing vs. looking down; Lang & Craske, 2000, Experiment 1). Although the random/variable 
group experienced higher peak levels of fear (self-report and heart rate) during exposure itself, 
the varying practice resulted in lower self-report general anxiety at 1-month follow-up. However, 
this finding did not extend to specific fears of heights or physiological measures.  
Two additional studies that have attempted to experimentally vary fear levels have failed 
to do so. First, in a sample of individuals fearful of public speaking, Culver and colleagues 
(2012) compared traditional public speaking exposure to exposure with additional hypothesized 
excitatory stimuli (presented either concurrently or sequentially), which were intended to 
enhance arousal and fear responding during exposure (i.e., a tightened workman’s belt designed 
to cause the sensation of chest restriction and a video camera connected to a monitor on which 
participants could view their performance). Contrary to hypotheses, however, the excitatory 
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stimuli did not result in increased fear responding or differential outcomes relative to the 
traditional exposure group. Second, in a sample of individuals with contamination fears, 
Kircanski and colleagues (2012) compared long-term outcomes for groups assigned to three 
weekly sessions of either “consistent and gradual” exposure to contaminants (to maximize 
habituation) or “random and variable exposure” to maximize variability. Again however, 
contrary to hypotheses both groups experienced significant decreases in subjective fear, with no 
differing long-term findings at two-week follow-up. Thus, while these preliminary findings are 
intriguing, study replication is certainly needed to (a) help clarify these mixed results, (b) 
investigate their applications beyond circumscribed fears of spiders, heights, public speaking, 
and germs, and (c) determine more effective ways of experimentally manipulating variability of 
fear responding using random/variable exposure.  
The Current Study 
While this preliminary research suggests that learning to tolerate varying levels of fear 
during exposure therapy enhances long-term outcomes for some anxiety-related problems, no 
previous studies have empirically examined this question in the treatment of individuals with 
primary obsessions (who may especially benefit from a random/variable approach). Accordingly, 
with the aim of translating the laboratory research described above to help improve ERP for an 
especially at-risk group, the current project compared the processes and outcomes (interview, 
self-report, behavioral, and psychophysiological) of two brief exposure-based interventions for 
unwanted obsessional thoughts. The gradual exposure condition (EXP-G) used the conventional 
ERP approach (i.e., emphasizing habituation and fear reduction) such that exposure intensity was 
gradually increased in a hierarchical manner. In contrast, the variable exposure condition (EXP-
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V) aimed to enhance inhibitory learning by maximizing variability in exposure intensity and 
corresponding physiological arousal.  
The two interventions (described in the Method section below) were intentionally brief 
and specific in order to maximize the study’s internal validity without sacrificing clinical utility. 
In particular, the interventions and outcome measures targeted only one of the participant’s 
obsessional thoughts. A feature of this study is that it included objective biological measures of 
therapeutic mechanisms and processes (i.e., continual measures of skin conductance and heart 
rate during exposure trials) along with the standard self-report assessments of anxiety, for more 
complete understanding of fear learning. Furthermore, in order to maximize the clinical utility of 
these findings, experimenters aided participants in ideographic exposure stimuli selection (to 
maximize the experimental manipulation of variability), and provided them with a rationale for 
EXP (i.e., explaining how variability can introduce “surprises” that are similar to real-world 
settings and help individuals practice “fear tolerance”), both of which have been lacking in 
previous research. Importantly, presenting a rationale allows therapists to cultivate a “bring it on” 
attitude, in which surges of anxiety can be labeled as “wanted challenges” and “opportunities” to 
practice learning new inhibitory associations, as opposed being labeled as signs of failure. 
Clinicians have anecdotally remarked that providing a sound rationale to explain the benefits of 
exposure variability allows patients to understand and engage in these difficult procedures 
(Craske, Treanor, Conway, Zbozinek, & Vervliet, 2014). However, these rationales had yet to be 
empirically examined in terms of credibility and acceptability. 
My hypotheses were as follows: First, given the demonstrated efficacy of exposure 
therapy for obsessions/OCD (e.g., Olatunji et al., 2012), I expected that both EXP conditions 
would produce significant immediate (POST) and longer-term (1MFU) reductions in obsessional 
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symptoms (Hypothesis 1). Furthermore, due to the predicted benefits of introducing variability 
into exposure (e.g., Bjork & Bjork, 2006; Lang & Craske, 2000; Rowe & Craske, 1998), I 
predicted that individuals receiving EXP-V would demonstrate superior outcome at long-term 
(i.e., 1-month) follow-up relative to individuals receiving EXP-G (Hypothesis 2). Finally, since 
previous studies have found fear variability (Culver et al., 2012; Kircanski et al., 2012), but not 
habituation (Craske et al., 2008), to be a consistent predictor of exposure therapy outcome, I 
hypothesized that in both conditions, average subjective (SUDS) and physiological (HR, SC) 
fear variability during exposure, but not habituation , would predict outcome for the target 
obsessional thought (Hypothesis 3). 
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METHOD 
Participants 
 Participants included 30 adults with a distressing unacceptable obsessional thought (i.e., 
about sex, immorality, religion, or harm) as determined by a structured clinical interview 
(described below). I elected to test my hypotheses in a non-clinical OC analog sample based on a 
body of research indicating that: (a) 80-99% of people in the general population experience 
unwanted intrusive thoughts similar in content to clinical obsessions (Belloch, Morillo, Lucero, 
Cabedo, & Carrió, 2004; Clark & de Silva, 1985; Rachman & de Silva, 1978; Radomsky et al., 
2014; Salkovskis & Harrison, 1984), and (b) “non-clinical obsessions” and clinical obsessions 
are associated with the same developmental and maintenance factors (Abramowitz et al., 2014). 
Accordingly, the study of non-clinical intrusive thoughts has the potential to inform the 
mechanisms involved in the treatment of clinically severe obsessions. 
Participants were recruited through the University of North Carolina at Chapel Hill 
(UNC-CH) Psychology Participant Pool, and received 4 hours of research credit as part of 
Introduction to Psychology (PSYC 101) in exchange for their participation (53.3%; n = 16). 
Participants were also recruited through the University community via informational emails, 
Internet advertisements (e.g., Join the Conquest), and flyers (46.7%; n = 14). The sample as a 
whole was primarily female (73.3%, n = 22), non-Latino (96.7%, n = 29), and Caucasian (70.0%, 
n = 21); 6.7% African American, 10.0% Asian, and 13.3% Biracial / Multiracial. The group’s 
mean age was 22.97 years (SD = 6.17; range = 18 – 39) and the mean number of years of 
education reported was 15.20 (SD = 3.63; range = 12 - 24), suggesting that the average 
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participant had completed at least some college. Participants were full-time students 
(undergraduate or graduate; 53.3%, n = 16), working full-time (30.0%, n = 9), or both in school 
and working part-time (16.7%, n = 5). The majority of participants had never been married 
(76.7%, n = 23; 10.0% married, 3.3% divorced or separated, 10.0% other/domestic partnership). 
Seventy percent (n = 21) of the sample reported ever previously receiving 
psychological/psychiatric treatment, and 46.7% (n = 14) reported currently receiving treatment. 
More specifically, 26.7% (n = 8) of the sample reported currently taking a stable dose of 
psychiatric medication, 10.0% (n = 3) were receiving ongoing supportive psychotherapy, and 
10.0% (n = 3) were taking both medication and receiving therapy.  
Study inclusion/exclusion criteria were as follows: Inclusion criteria: (a) at least 18 
years old; (b) willing to attend and audiotape all study sessions; (c) fluent in English; (d) 
presence of one or more obsessional thoughts about sex, immorality, religion, or harm (and not 
primarily related to another construct such as trauma, eating disorders, or generalized worry) that 
cause marked distress (as defined below); (e) if on a psychiatric medication (e.g., anti-depressant 
medication), willing to remain at a fixed dose while participating in the study (and stabilized on 
medication for 30 days before beginning). Exclusion criteria: (a) previous cognitive-behavioral 
therapy (CBT) for anxiety (to eliminate the possible confound of having received different 
messages about the rationale and methods of exposure); (b) current suicidal ideation; (c) current 
substance use disorder; (d) current mania or psychosis; and due to interference with 
psychophysiological measures: (e) currently taking an acute anxiolytic (e.g., Ativan) or stimulant 
(e.g., Ritalin) medication; (f) any heart, respiratory, or neurological condition; or (g) current 
pregnancy. 
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Measures 
An independent evaluator (IE) blind to experimental condition administered the 
following outcome and process measures (see Table 1 for administration schedule). 
Mini-International Neuropsychiatric Interview (MINI: Sheehan et al., 1998). The 
MINI is a structured diagnostic interview to determine clinical diagnoses with adequate 
psychometric properties and a strong correlation with the Structured Clinical Interview for the 
Diagnostic and Statistical Manual for Mental Disorders (SCID; Sheehan et al., 1997). The 
following modules were administered to determine exclusion criteria: (a) manic and hypomanic 
episodes, (b) suicidality, (c) alcohol/substance use disorder, and (d) psychotic disorders. 
Yale-Brown Obsessive Compulsive Scale (Y-BOCS; Goodman, Price, Rasmussen, & 
Mazure, 1989a, 1989b). The Y-BOCS is a widely used interview measure of OCD symptoms 
that includes a 10-item severity scale of good reliability, validity, and sensitivity to change 
following treatment. The Y-BOCS checklist was administered by phone to determine the 
participants’ most distressing intrusive thought (i.e., the thought to be targeted in the study’s 
intervention), and any related compulsive or neutralizing behaviors. Severity ratings were 
assessed in person by an IE blind to experimental condition, and focused on only this thought 
and related compulsions. These ratings assess the severity of obsessions and compulsions on the 
following five parameters: (a) time, (b) interference, (c) distress, (d) resistance, and (e) control; 
total scores range from 0 to 40 and scores above 16 indicate clinical levels of OCD symptoms. 
The Y-BOCS was the primary interview outcome measure. Internal consistency of the Y-BOCS 
in the present sample was good (D = .84). 
Dimensional Obsessive-Compulsive Scale–Unacceptable Thoughts (DOCS-UT; 
Abramowitz et al., 2010). The DOCS-UT is self-report measure of the unacceptable thoughts 
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(UT) OC symptom dimension (i.e., the type of obsessions targeted in the current study). The 
measure begins with examples of representative UT obsessions (e.g., “Unpleasant thoughts about 
sex, immorality, or violence that come to mind against your will”) and compulsions (e.g., 
“Mentally performing an action or saying prayers to get rid of an unwanted or unpleasant 
thought”). The measure then has five items (rated 0 to 4) assessing the following parameters of 
current UT symptom severity: (a) time occupied by obsessions and compulsions, (b) avoidance 
behavior, (c) associated distress, (d) functional interference, and (e) difficulty disregarding 
obsessions and resisting compulsive urges; DOCS-UT total scores range from 0 to 20. The 
DOCS has good to excellent reliability in clinical and undergraduate samples, and converges 
well with other OCD measures. The DOCS-UT was the primary self-report outcome measure. 
Internal consistency of the DOCS-UT in the present sample was good (D = .83). 
In addition, for the purposes of the present study, the first three items of the Interpretation 
of Intrusions Inventory (III-31; Obsessive Compulsive Cognitions Working Group, 2003, 2005) 
were included to gather baseline descriptive information about the UT. Specifically, participants 
were asked: (a) how long ago they last experienced the intrusive thought, (b) how often they 
experienced the intrusive thought in the last six months, and (c) the average level of distress they 
have when experiencing an intrusion on a scale from 0 (None) to 5 (Extreme).  
Beck Depression Inventory (BDI-II; Beck, Steer, & Brown, 1996). The BDI-II is a 21-
item self-report scale that assesses the affective (e.g., guilt), cognitive (e.g., decision making 
difficulties), motivational (e.g., social withdrawal), vegetative (e.g., loss of appetite), and 
psychomotor (e.g., fatigue) components of depression. Total scores range from 0 to 63. Scores of 
10 or less are considered normal; scores of 20 or greater suggest the presence of clinical 
depression. The BDI-II has excellent reliability and validity as a measure of general distress, and 
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is widely used in clinical research (Beck et al., 1996; Sprinkle et al., 2002; Steer, Ball, Ranieri, & 
Beck, 1999). Internal consistency of the BDI-II in the present sample was good (D = .89). 
Behavioral Approach Test (BAT; Steketee, Chambless, Tran, & Worden, 1996). IEs 
blind to experimental condition administered an in vivo measure of participants’ responses to 
their target obsession (i.e., discomfort, willingness to experience). Specifically, participants were 
asked to complete a series of increasingly difficult tasks related to their unacceptable thought: (a) 
Say the thought aloud, (b) Write the thought down on a piece of paper, (c) Write the thought on 
their hand in ink, (d) Say “I will never know for certain whether one day [the thought] might 
come true,” (e) Say “I hope and pray [the thought] comes true.” Participants were instructed to 
complete as many tasks as they could, and to inform the experimenter if there were any tasks 
they did not wish to complete because they were too difficult, thus providing a behavioral 
measure of task completion (0-5). Participants were also asked to report after each step if they 
performed a neutralizing ritual from a list of options (e.g., distracted themselves from the thought 
or reassured themselves it was just a thought). The number of steps participants were able to 
complete without performing a ritual was also calculated (0-5). 
Additionally, subjective fear was monitored using the Subjective Units of Distress Scale 
(SUDS; Wolpe, 1973) on a scale from 0 (No distress/fear/anxiety) to 100 (Extreme 
distress/fear/anxiety). Participants provided SUDS ratings after the completion of each BAT task, 
as well as every 1 minute during EXP sessions. From these ratings, I calculated the mean SUDS 
levels across the 5 BAT tasks. Internal consistency of the SUDS ratings on the BAT was 
excellent (D =.92). Skin Conductance (SC) and Heart Rate (HR) were used as objective 
physiological measures of fearful responding (i.e., arousal) during the BAT and EXP sessions. 
Both SC and HR be measured using the BioPac MP150 system. 
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Credibility/Expectancy Questionnaire (CEQ; Devilly & Borkovec, 2000). The CEQ is 
a 6-item measure that divides into two subscales (3 items each). The treatment rationale 
credibility (CEQ-C) subscale is more cognitively based (e.g., “How logical does the therapy 
offered to you seem?”), and items are rated on a scale from 1 (Not at all) to 9 (Very). The 
treatment expectancy (CEQ-E) subscale is more emotionally based (e.g., “How much do you 
really feel that therapy will help you to reduce your symptoms?”), with one item on the 
aforementioned 1-9 Likert scale the other and two items rated on a scale form 0-100%. Thus, 
CEQ-E subscale scores are calculated by first standardizing the three items to z-scores before 
summing to create total expectancy score. The CEQ has demonstrated adequate internal 
consistency, and test-retest reliability in previous research (Devilly & Borkovec, 2000). It also 
predicts favorable CBT treatment outcomes for anxiety (Devilly & Borkovec, 2000; Newman & 
Fisher, 2010). Internal consistency of the CEQ subscales in the present sample were acceptable 
to good (D =.75-.81). 
Client Satisfaction Questionnaire (CSQ; Nguyen, Attkisson, & Stegner, 1983). The 
CSQ is a widely used 8-item post-intervention measure of treatment satisfaction. A modified 
version was used in the present study to more specifically refer to the method participants 
learned to manage their unwanted intrusive thought (e.g., “Has the method you learned helped 
you to deal more effectively with your intrusive thought?”). Each item is rated using a 4-point 
Likert scale, with higher scores reflecting greater treatment satisfaction; total scores range from 8 
to 32. In previous studies, the CSQ has demonstrated high internal consistency, as well as 
criterion and construct validity (Larsen, Attkisson, Hargreaves, & Nguyen, 1979; Nguyen et al., 
1983). It has been used previously in studies examining patient satisfaction with exposure 
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therapy (Tolin, Diefenbach, & Gilliam, 2011). Internal consistency of the CSQ in the present 
sample was excellent (D = .92). 
Procedure 
Recruitment and pre-screening. Undergraduates enrolled in Psychology 101 completed 
the DOCS-UT as part of the Psychology Participant Pre-Screening Instrument, and individuals 
with the highest scores were invited to participate in the study using the confidential messaging 
system within the Participant Pool web-based software (SONA). Unselected community 
members heard about the study from flyers, email advertisements, etc. Specifically, the study 
was described as being about “Methods for Managing Intrusive Thoughts.” Individuals were 
informed that during this study they would receive 4 twice-weekly 60 minute study sessions that 
would involve learning a strategy that may help them better manage unwanted intrusive thoughts, 
and that they would be re-contacted for two follow-up sessions 1- and 3-months later. Those who 
were interested were asked to contact the study experimenter via email and provide their first 
name, phone number, and availability for a 15 minute phone conversation. The experimenter 
then scheduled a phone screening during one of the participant’s listed available times. Eighty-
three participants conducted a phone screen to determine study eligibility. 
In the telephone interview, the experimenter explained the study procedures and asked a 
series of questions that determine potential participant eligibility. Specifically, the experimenter 
administered the Y-BOCS checklist in order to identify and obtain a description of an 
unacceptable, intrusive thought that the individual found most distressing (and determine that it 
was not primarily related to another construct such as trauma, eating disorders, or generalized 
worry). The experimenter also assessed the degree of distress caused by this thought (i.e., “How 
distressing is it when [this thought] comes into your mind?” on a scale from 0 [No distress] to 8 
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[Extreme distress]) in order to identify those with “moderate” distress (i.e., score of  > 4; Brown 
& Barlow, 2014).  
Of those screened, 45 participants were not eligible for the study (54%). Of those 
ineligible at the phone screen, 4% (n = 2) were not interested in participating after hearing the 
complete study description (e.g., since financial compensation was not provided for all study 
visits), 11% (n = 5) were not eligible due to endorsing one of the initial exclusionary screening 
questions (i.e., medical condition, pregnancy, previous diagnosis of bipolar disorder or 
schizophrenia, problematic use of substances in the last 6 months), and 9% (n = 4) were currently 
taking a psychiatric medication that was exclusionary (e.g., Ritalin). Furthermore, 62% (n = 28) 
were ineligible because they were unable to identify an unacceptable thought in line with the 
study definition (which was the most common reason for exclusion), and 13% (n = 6) reported 
that their unacceptable thought was only mildly distressing.  
Individuals who appeared to meet initial inclusion/exclusion criteria were invited to an 
in-person appointment (n = 38; 46%). Of those scheduled, 5 cancelled before coming in for the 
first visit saying that they no longer could participate in the study (e.g., due to the time 
commitment or other personal reasons). Additionally, 3 participants were determined to be 
ineligible at the in-person assessment at session 1 (e.g., due to substance use problems or suicidal 
ideation assessed more thoroughly in person), resulting in a final sample size of 30 participants 
who were eligible and enrolled in the study. 
Overview. All participants were tested individually in the Anxiety and Stress Disorders 
Clinic (ASDC) laboratory in Coker Hall. Data were collected over six sessions: (a) baseline 
assessment (PRE, Session 1, 60 minutes); (b) three twice-weekly exposure sessions (Sessions 2-4, 
45-60 minutes), with the last exposure session followed immediately by post-assessment (POST, 
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30 minutes); and (c) one follow-up assessment 1-month after post (1MFU, 30 minutes). On the 
day of study appointments, participants were asked to comply with the following instructions due 
to their possible effects on physiological measures: (a) on the day of the assessment: refrain from 
using alcohol, recreational drugs, or any anti-anxiety, sleep, or stimulant medications, (b) for two 
hours prior to the session: refrain from using caffeinated or tobacco products. Table 2 includes a 
summary of the components of each study session.  
Session 1. Following informed consent, a study experimenter confirmed the most 
problematic obsessional thought with the participant (identified in the phone screen and to be 
targeted during the study) and conducted the MINI in order to determine study eligibility. The 
participant also completed the BDI-II on paper. Emergency procedures were enacted if a 
participant endorsed suicidal thoughts on either the MINI or BDI-II (score ≥ 1 on either module). 
As part of this process, the experimenter conducted a direct assessment of suicidality, and 
immediately contacted Dr. Abramowitz as necessary. Then, the evaluator conducted the Y-
BOCS severity scale (10-15 minutes). Subsequently, the participant completed several 
demographic (age, gender, race/ethnicity, and years of education) and self-report questionnaires 
(i.e., DOCS-UT) using the secure web survey program Qualtrics (10-15 minutes). Next, 
participants completed the BAT (described in the Measures section above).  
Following these assessment procedures, a separate study experimenter took over the 
session from the evaluator. This experimenter randomly assigned the participant (using a random 
number generator) to one of the two experimental conditions: 14 received EXP-G, and 16 
received EXP-V. They next provided psychoeducation about the cognitive-behavioral 
conceptualization of unwanted intrusive thoughts and delivered the rationale for EXP from the 
appropriate perspective: In EXP-G, this rationale emphasized the goal of habituation in order to 
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reduce obsessional fear (e.g., 50% reduction in SUDS ratings). In EXP-V, the rationale 
emphasized exposure to varying levels of fear in order to practice fear tolerance and maximize 
surprise. The experimenter and participant generated a list of nine total exposure stimuli (see 
examples in Table 3 that correspond to the clinical case example of Cindy described above and 
are based on actual participant hierarchies with similar intrusive thoughts), categorized by the 
intensity of distress they are anticipated to provoke (three stimuli each of mild, moderate, and 
high intensity). Finally, participants completed the CEQ about the credibility of the EXP 
rationale and their expectancies for EXP. 
Sessions 2-4. When participants first arrived, they were asked about the presence (over 
the previous 2 hours) of a variety of health-related behaviors that are known affect physiological 
measures (i.e., caffeine, tobacco, drugs/alcohol, exercise, sleep, food, medications, illnesses). 
Only one participant endorsed consuming half a cup of coffee in the 2 hours prior to one of the 
three study visits.2  Next, several electrodes filled with electrolyte gel were placed on participants’ 
skin. Specifically, to measure SC, two electrodes were placed on the middle segment of the index 
and middle fingers of the participant’s non-dominant hand. To measure HR, three electrodes 
were placed on the participant’s torso (right and left collar bone and below the last rib on the left 
side). In order to place the HR electrodes, the experimenter first lightly abraded the skin using an 
abrasion gel. 
After a 5 minute acclimation period allowing the electrodes to settle, a 3 minute baseline 
period was conducted before the exposures begin. During this time, participants read from a 
neutral reading comprehension passage (i.e., about discoveries in science; 8th grade reading 
level) and physiological data were collected to determine baseline measures of participants’ 
                                                 
2Accordingly, given that the majority of participants reported refraining from these health-related 
behaviors, there was no need to control for these behaviors in statistical analyses. 
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physiological responding. SUDS levels were also recorded every 1 minute. 
Each of these sessions then included three in-session exposures to the identified 
obsession lasting for approximately 8 minutes each (i.e., approximately 25 minutes total of 
exposure per session; Foa et al., 2012; Freeston et al., 1997). Three exposure-based sessions 
were expected to be sufficient for testing hypotheses about processes and outcome because the 
intervention was targeting only one obsession (i.e., one hierarchy item). In EXP-G, exposure 
proceeded gradually (hierarchically) from mildly, to moderately, to highly intense stimuli so that 
exposure intensity would gradually build between (but not within) sessions. The aim of each 
exposure session was habituation of distress, defined as ≥ 50% reduction in SUDS.  
In EXP-V, the exposure stimuli in each session were chosen at random so that mild, 
moderate, and high intensity exposures could occur in any order during any of the sessions (the 
participant was not informed which level was coming next). This aimed to maximize (a) 
uncertainty, (b) variability in exposure intensity, and (c) variability in corresponding 
physiological arousal – each of which has been shown to facilitate inhibitory learning (Craske et 
al., 2008; Rescorla & Wagner, 1972). Although the experimenter tracked SUDS ratings, the 
emphasis was on tolerating the uncertainty and distress provoked by the randomly chosen stimuli 
rather than on habituation. In both conditions, the experimenter helped the participant refrain 
from anxiety-reducing behaviors (e.g., rituals, thought suppression). Importantly, across the three 
exposure sessions, the two EXP conditions involved the same total amount of exposure to mildly, 
moderately, and highly intense stimuli. This allowed us to manipulate process, while controlling 
for average exposure intensity.  
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Session 4 also included a discussion of relapse-prevention from the appropriate 
perspective. Moreover, the participant completed the post assessment immediately following the 
final exposure in Session 4 (see below).  
Post and follow-up visits. The POST and 1MFU follow-up assessment visits were 
conducted by the IE who remained blind to EXP condition and included the administration of the 
previously described interview, self-report, and behavioral measures. At POST, the participant 
also complete the CSQ to rate his or her experience in the study, and at the 1MFU visit the 
experimenter recorded whether the participant had made any changes to his/her pre-existing 
psychological/psychiatric treatment. At the final visit, the participant was debriefed about the 
nature of the study and provided with referrals and resources in case they wished to receive 
treatment or further information about intrusive thoughts or OCD. Any participants who 
indicated that they wished to withdraw from the study prematurely were followed up with in 
order to determine reasons for dropout and whether they were either related to the study design 
(e.g., the procedures were overly anxiety-provoking) or unrelated (e.g., they were studying 
aboard) in order to determine the extent to which the data obtained was missing “not at random.” 
Reimbursement. Students received 4 hours of credit toward the research requirement of 
PSYC 101 for Sessions 1-4 and community members learned methods for managing intrusive 
thoughts at no charge. All participants received $20 compensation for attending the 1MFU visit. 
Data Analytic Strategy 
Data reduction. Due to the multiple subjective fear ratings (i.e., SUDS) and the 
continuous measurement of physiological indices of fear (i.e., SC and HR) during EXP sessions, 
the following data reduction calculations were made in a manner consistent with previous 
research (e.g., Kircanski et al., 2012): (a) Baseline Fear: average SUDS, SCL, and HR levels 
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during the 3 minute baseline period prior to the first EXP task of the session (before the task was 
described); (b) Peak Fear: highest SUDS, SCL and HR levels for each EXP session, (c) Mean 
Fear: average SUDS, SCL, and HR levels for each EXP session, (d) Final Fear: final SUDS 
rating, and mean SCL and HR levels for the final minute of each EXP session.  
These values were then used to calculate the following process measures in order to 
evaluate the degree to which habituation and variability in emotional responding during exposure 
were predictors of outcome. First, within-session habituation (WSH) was calculated (Foa & 
Kozak, 1986; Foa & McNally, 1996) as peak fear minus final fear level; averaged across the 3 
EXP sessions). In addition, fear variability was calculated in two ways: (a) amplitude of intra-
individual fluctuations of fear (i.e., intra-individual standard deviation [ISD] of fear; averaged 
across the 3 EXP sessions), and (b) temporal dependency of intra-individual fluctuations of fear 
(i.e., first-order autoregressive parameter [AR] of fear measures; degree to which fear levels 
close in time are more strongly correlated than fear levels farther apart in time). This parameter 
was calculated by fitting a first-order autoregressive time series model to each participant’s EXP 
data for each EXP session and extracting the autoregressive parameter for each individual to use 
as a predictor (averaged across the 3 EXP sessions). A low AR parameter means that an 
individual’s data is characterized by relatively independent (i.e., variable) scores over time. 
Preliminary analyses. First, descriptive statistics (means, standard deviations, and 
range) were computed on all variables. Second, baseline differences between groups on socio-
demographic (age, gender, race/ethnicity, and years of education) and clinical (i.e., Y-BOCS, 
DOCS-UT, BDI-II, BAT) variables were assessed using appropriate chi-square and independent 
samples t-tests. Pearson’s correlations examined the simple relationships among baseline study 
variables in the sample as a whole. I also examined CEQ and CSQ means to determine the 
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degree to which participants found EXP-G and EXP-V credible and acceptable; group 
differences on these measures were investigated using independent samples t-tests. 
Primary analyses. Due to the nested structure of the data (i.e., three primary assessment 
time points per participant: Session 1/PRE, Session 4/POST, 1MFU), I used multi-level 
modeling (MLM; Raudenbush & Bryk, 2002) to address each of the hypotheses described below. 
MLM provides unbiased and accurate estimates of regression coefficients even in small samples 
(Maas & Hox, 2005), and is the recommended method for analyzing treatment outcome data 
(Hamer & Simpson, 2009). The model predictors included: (a) experimental condition (Level 2; 
EXP-G vs. EXP-V; dummy coded 0 and 1 respectively, such that a main effect of experimental 
condition suggests an effect of EXP-V above and beyond EXP-G), (b) EXP indices of 
habituation and variability of fear as defined above (Level 2; WSH, ISD, AR averaged across the 
3 EXP sessions), and (c) session number (Level 1; nominally coded; i.e., making no assumptions 
about the time spacing in between sessions). Outcome measure included: (a) interview (i.e., Y-
BOCS), (b) self-report (i.e., DOCS-UT), and (c) in vivo/behavioral (i.e., mean SUDS, 0-100; 
BAT number of tasks completed without rituals, 0-5) indices. 
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RESULTS 
Baseline Characteristics and Group Comparisons 
Clinical characteristics of unacceptable thoughts. Participants reported a variety of 
different unacceptable thoughts (UTs). The majority (70%, n = 21) identified their primary UT 
(i.e., the thought they found to be most distressing and thus that they targeted in the study) as 
having to do with violence, aggression, or harm (e.g., the impulse or image of stabbing a loved 
one with a sharp object). Seventeen percent of participants reported a primary UT about 
something immoral or uncharacteristic of them (n = 5; e.g., the sudden thought or impulse to yell 
out a derogatory comment), 3% reported a primary unwanted sexual intrusive thought (n = 1; e.g., 
the doubt having sexually objectified someone else), 3% reported a primary religious intrusive 
thought (n = 1; e.g., the doubt of having done something that might upset God), and 7% reported 
a primary intrusive thought that did not fall into one of the predetermined categories (n = 2; e.g., 
about needing to know and remember things). The majority of the sample reported experiencing 
their UT in the past week (73.4%; n = 22; 23.3% in the last month; 3.3% in the last 6 months). 
When asked how often they experience their thought in the last six months, 33.3% said once or 
more per day (n = 10; 60.0% once or more per week; 6.7% once a month). The average level of 
distress participants reported when experiencing an intrusion was “moderate” (M = 3.00, SD = 
0.81); distress levels covered almost the entire range of the scale (range = 1-4). 
EXP group comparisons on demographic variables and baseline self-report 
measures. First, EXP group differences in recruitment method were examined. There were no 
differences in the percentage of PSYC 101 versus community member participants in the two 
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EXP groups (percentage PSYC 101: 42.9% in EXP-G, 62.5% in EXP-V), F2(1) = 1.16, p = .28. 
Demographic characteristics of the two EXP groups, and the results of independent samples t-
tests and chi-square tests examining group differences, appear in Table 4. As can be seen, there 
were similarly no significant age, gender, race, or education differences between the two groups.  
Next, I examined group mean scores on the baseline interview, self-report, and 
behavioral symptom measures, along with the results of independent samples t-tests examining 
group differences. Group mean scores on these symptom measures by EXP group and by time 
point (PRE, POST, and 1MFU) appear in Table 5. There were no significant baseline EXP group 
differences for any of the clinical measures: (a) Y-BOCS scores, t(28) = -0.08, p = .93, (b) 
DOCS-UT scores, t(28) = 0.03,  p = .98, (c) BAT mean SUDS levels, t(28) = -1.04, p = .31, and 
(d) BAT number of steps completed without rituals, t(28) = 0.32,  p = .75. 
In the sample as a whole, the mean pre-treatment Y-BOCS score was moderate and 
slightly above the clinical cut-off of 16 (Goodman et al., 1989a, 1989b). The DOCS-UT score 
was slightly lower than a sample of treatment-seeking patients with OCD (M = 9.73, SD = 6.20) 
and yet higher than that from a group of unscreened undergraduate students (M = 3.08, SD = 
3.25; Abramowitz et al., 2010). The mean BDI-II score indicated minimal/mild levels of 
depressive symptoms (Beck et al., 1996).  All participants were able to complete either 4 or all 5 
steps on the BAT at PRE; however, on average they only completed between 2 – 3 steps without 
performing a mental ritual or neutralization behavior (range = 0 – 5 steps). Specifically, across 
the 5 BAT tasks, the frequency of rituals participants employed included: no rituals performed 
(48%), suppression (8%), distraction (6%), neutralizing (3%), analyzing (7%), reassurance 
(14%), other (3%; e.g., deep breathing), or more than one ritual (10%). On average, participants 
experienced moderate levels of subjective distress during the BAT tasks, which was comparable 
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to subjective fear ratings in a previous study using a BAT for contamination fears in an analog 
sample (Kircanski et al., 2012). 
Correlations among baseline symptom measures. Zero-order Pearson’s correlations 
examined the simple relationships among baseline interview, self-report, and behavioral study 
measures in the sample as a whole and appear in Table 6. As can be seen, there was a significant, 
strong positive association between our clinical interview (Y-BOCS) and self-report (DOCS-UT) 
measures of the UT. In addition, Y-BOCS symptom severity and mean SUDS during the BAT, 
were each significantly, weakly negatively correlated with our behavioral measure of confronting 
the UT (i.e., the number of BAT tasks participants completed without performing a ritual). 
Specifically, the more elevated participant UT symptoms and distress during the BAT, the fewer 
steps of the BAT they were able to complete without ritualizing. Scores on the BDI-II were not 
significantly associated with any other study measures. 
Group Comparisons of Treatment Credibility/Expectancy, Satisfaction, and Drop-out 
Next, I examined CEQ and CSQ means to determine the degree to which participants 
found EXP-G and EXP-V credible and acceptable (See Table 5); group differences on these 
measures were investigated using independent samples t-tests. First, there were no differences on 
participant-rated credibility of the two exposure rationales, t(28) = 0.68, p = .50, or their 
expectancies of improvement over the course of the two interventions, t(28) = 1.33, p = .20. On 
average, participants in both the gradual and variable EXP groups thought the treatment rationale 
was between “somewhat” and “very” logical and expected to see approximately 50% reduction 
in their intrusive thought symptoms over the course of the study.  
Similarly, there were no group differences in terms of how satisfied participants were 
with the exposure exercises they received, t(24) = -0.28, p = .78. Participants reported 
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satisfaction levels that approached those of individuals receiving a standard package of ERP in a 
clinical setting (Ms = 29.00-29.92; Tolin et al., 2011). Participant free-form responses in 
describing their feedback regarding the interventions stated that they learned a new outlook 
toward their UT (e.g., that by placing undue focus on unwanted thoughts they keep coming back), 
that they found the techniques useful (e.g., the “scripts” as a tool to face the UT), that they plan 
to continue to practice the techniques, and that they saw an improvement in their quality of life.  
Of the entire sample, 4 participants (13.3%) dropped out prematurely from the study; all 
4 were in the EXP-G condition. Of these, 1 participant dropped after the first session (i.e., before 
beginning any exposure exercises) and reported that her reason for drop out was realizing the 
study was too much of a time commitment for her schedule. The other 3 participants dropped 
after Session 2 (i.e., between the first and second exposure sessions). Each stated a logistical 
reason for dropping (e.g., difficulty getting to the UNC campus, too many other time 
commitments) and 2 of the participants explicitly mentioned that the tasks were “anxiety-
provoking” and induced additional “emotional stress” as another reason for discontinuing. Only 
one participant reported any changes in psychological/psychiatric treatment over the course of 
the follow-up period (he wrapped up his short-term supportive psychological treatment at 
Counseling and Psychological Services). 
Exposure Process Characteristics 
There were no EXP group differences on the duration of exposure exercises: EXP-G: 
8.07 minutes (SD = 0.67) vs. EXP-V: 7.90 minutes (SD = 0.63); t(27) = 0.73, p = .47. Table 7 
presents descriptive statistics for the exposure process variables for participants who completed 
the intervention. The SC and HR data was removed for one participant who reported that she had 
a diagnosis of hyperhidrosis, which led to abnormal physiological readings. Additionally, SC 
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data was removed for one participant who failed to display any SC reactivity across the three 
exposure sessions. As can be seen, participants evidenced mild to moderate subjective distress 
over the course of the exposure sessions. They experienced 43% reduction in their SUDS, 29% 
reduction in SCL, and 24% reduction in HR levels on average over the course of the exposure 
sessions (i.e., from peak to final fear). 
Primary Analyses 
For the subsequent multi-level model analyses, I compared three different options for 
modeling the error structures: (1) an unrestricted covariance matrix, (2) compound symmetric 
residuals (i.e., assuming “homoscedasticity” or constant error variance over time), and (3) 
autoregressive residual variance (i.e., assuming decaying correlations over time for increasingly 
spaced time points). I then compared values for the Bayesian Information Criterion (BIC; 
Schwarz, 1978) for each of the three models. The BIC is a criterion that aids in model selection 
and applies a penalty based on the number of model parameters such that the optimal fitted 
model is identified by the minimum BIC. Across the various outcome measures, modeling the 
residuals using compound symmetric residuals produced the lowest (i.e., preferred) BIC. Given 
that compound symmetric models are also the most parsimonious (and thus aid in interpretation 
of estimates), and since visual inspection did not suggest decaying correlations of the error 
variances, I elected to use the compound symmetric model in subsequent analyses.  
To address hypotheses 1-2, I first fit a model with session number as a nominal, time-
varying predictor and experimental condition (EXP-G vs. EXP-V) as a time-invariant predictor 
predicting each of the outcome measures (i.e., Y-BOCS, DOCS-UT, BAT mean SUDS, and 
BAT number of steps completed without a ritual). Univariate and bivariate residual distribution 
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plots demonstrated that the Level 1 and Level 2 residuals were normally distributed and 
homoscedastic and that there were no problematic trends in the data.  
Hypothesis 1. First, to examine the hypothesis that both EXP conditions would produce 
significant immediate (POST) and longer-term (1MFU) reductions in obsessional symptoms, I 
used planned comparisons to examine whether the changes in each of the four outcome measures 
from PRE to POST and from POST to 1MFU were significantly different from zero for both the 
EXP-G and EXP-V groups. For the first outcome of interest, the simple contrast was significant 
when comparing Y-BOCS scores at PRE vs. POST for both EXP groups, F(2, 44) = 23.65, p 
<.0001, suggesting that Y-BOCS scores significantly changed from pre- to post-treatment. 
Specifically, the model estimated Y-BOCS score decreased significantly by 8.42 points from 
PRE to POST for the EXP-G group, t(44) = -4.81, p < .0001, and decreased significantly by 7.13 
points from PRE to POST for the EXP-V group, t(44) = -4.91, p < .0001. However, the simple 
contrast was not significant when comparing Y-BOCS scores at POST vs. 1MFU for both EXP 
groups, F(2, 44) = 0.72, p = 0.49, suggesting that there was not significant return of fear in Y-
BOCS scores over the follow-up period. Specifically, the model estimated Y-BOCS score did 
not change significantly from POST to 1MFU for the EXP-G group (model estimated change = 
1.33 points), t(44) = 0.70, p = .49; or the EXP-V group (model estimated change = -1.44 points), 
t(44) = -0.97, p = .34. 
For the second outcome, the simple contrast was similarly significant when comparing 
DOCS-UT scores at PRE vs. POST for both EXP groups, F(2, 44) = 22.37, p <.0001, suggesting 
that DOCS-UT scores significantly changed from pre- to post-treatment. Specifically, the model 
estimated DOCS-UT score decreased significantly by 2.93 points from PRE to POST for the 
EXP-G group, t(44) = -3.93, p = .0003, and decreased significantly by 3.31 points from PRE to 
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POST for the EXP-V group, t(44) = -5.42, p < .0001. However, the simple contrast was not 
significant when comparing DOCS-UT scores at POST vs. 1MFU for both EXP groups, F(2, 44) 
= 2.82, p = 0.07, suggesting that there was not significant return of fear in DOCS-UT scores over 
the follow-up period. Specifically, the model estimated DOCS-UT score did not change 
significantly from POST to 1MFU for the EXP-G group (model estimated change = -0.87 points), 
t(44) = -1.09, p = .28. The model estimated DOCS-UT score did, however, continue to decrease 
significantly by 1.32 points from POST to 1MFU for the EXP-V group, t(44) = -2.11, p = .04. 
For the third outcome, the simple contrast was significant when comparing BAT mean 
SUDS levels at PRE vs. POST for both EXP groups, F(2, 44) = 20.57, p <.0001, suggesting that 
BAT mean SUDS levels significantly changed from pre- to post-treatment. Specifically, the 
model estimated BAT mean SUDS levels decreased significantly by 20.46 units from PRE to 
POST for the EXP-G group, t(44) = -3.64, p = .0007, and decreased significantly by 24.29 units 
from PRE to POST for the EXP-V group, t(44) = -5.28, p < .0001. However, the simple contrast 
was not significant when comparing BAT mean SUDS levels at POST vs. 1MFU for both EXP 
groups, F(2, 44) = 0.09, p = 0.92, suggesting that there was not significant return of fear in BAT 
mean SUDS levels over the follow-up period. Specifically, the model estimated BAT mean 
SUDS levels did not change significantly from POST to 1MFU for the EXP-G group (model 
estimated change = -1.53 units), t(44) = -0.25, p = .80; or the EXP-V group (model estimated 
change = -1.54 units), t(44) = -0.33, p = .76. 
For the fourth and final outcome, the simple contrast was significant when comparing the 
BAT number of steps completed without performing a ritual at PRE vs. POST for both EXP 
groups, F(2, 44) = 18.68, p <.0001, suggesting that the number of steps completed significantly 
changed from pre- to post-treatment. Specifically, the model estimated BAT steps completed 
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without rituals increased significantly by 1.61 steps from PRE to POST for the EXP-G group, 
t(44) = 4.02, p = .0002, and increased significantly by 1.50 steps from PRE to POST for the 
EXP-V group, t(44) = 4.60, p < .0001. However, the simple contrast was not significant when 
comparing BAT steps completed without rituals at POST vs. 1MFU for both EXP groups, F(2, 
44) = 0.36, p = 0.70, suggesting that there was not significant return of fear measured 
behaviorally using the BAT over the follow-up period. Specifically, the model estimated BAT 
steps completed without rituals did not change significantly from POST to 1MFU for the EXP-G 
group (model estimated change = -0.35 steps), t(44) = -0.82, p = .42; or the EXP-V group (model 
estimated change = -0.08 steps), t(44) = -0.23, p = .82. 
Hypothesis 2. To examine the second hypothesis that individuals receiving EXP-V 
would demonstrate superior outcome at long-term follow-up relative to individuals receiving 
EXP-G, I used planned comparisons to examine whether experimental condition (EXP-G vs. 
EXP-V) predicted changes in each of the four outcome measures from PRE to POST and from 
POST to 1MFU (i.e., two-way cross-level EXP condition x time interactions). For the first 
outcome of interest, the simple contrast was not significant when comparing the difference 
between the EXP-G and EXP-V Y-BOCS changes from PRE to POST, t(44) = -0.57, p  = 0.57. 
This suggests that the changes in Y-BOCS scores from PRE to POST were not significantly 
different for the two groups (model estimated difference in changes = -1.30 points). The simple 
contrast was also not significant when comparing the difference between the EXP-G and EXP-V 
Y-BOCS changes from POST to 1MFU, t(44) = 1.15, p  = 0.26. This suggests that the changes in 
Y-BOCS scores from POST to 1MFU were not significantly different for the two groups (model 
estimated difference in changes = 2.77 points). 
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For the second outcome, the simple contrast was not significant when comparing the 
difference between the EXP-G and EXP-V DOCS-UT changes from PRE to POST, t(44) = 0.39, 
p  = 0.70. This suggests that the changes in DOCS-UT score from PRE to POST were not 
significantly different for the two groups (model estimated difference in changes = 0.38 points). 
The simple contrast was also not significant when comparing the difference between the EXP-G 
and EXP-V DOCS-UT changes from POST to 1MFU, t(44) = 0.44, p  = 0.66. This suggests that 
the changes in DOCS-UT scores from POST to 1MFU were not significantly different for the 
two groups (model estimated difference in changes = 0.45 points). 
For the third outcome, the simple contrast was not significant when comparing the 
difference between the EXP-G and EXP-V BAT mean SUDS changes from PRE to POST, t(44) 
= 0.53, p  = 0.60. This suggests that the changes in BAT mean SUDS levels from PRE to POST 
were not significantly different for the two groups (model estimated difference in changes = 3.83 
units). The simple contrast was also not significant when comparing the difference between the 
EXP-G and EXP-V BAT mean SUDS changes from POST to 1MFU, t(44) = 0.00, p  = 0.99. 
This suggests that the changes in DOCS-UT scores from POST to 1MFU were not significantly 
different for the two groups (model estimated difference in changes = 0.002 units). 
For the fourth and final outcome, the simple contrast was not significant when comparing 
the difference between the EXP-G and EXP-V changes in BAT number of steps completed 
without performing a ritual from PRE to POST, t(44) = 0.21, p  = 0.83. This suggests that the 
changes in BAT steps completed without rituals from PRE to POST were not significantly 
different for the two groups (model estimated difference in changes = 0.11 steps). The simple 
contrast was also not significant when comparing the difference between the EXP-G and EXP-V 
changes in BAT steps completed without rituals from POST to 1MFU, t(44) = -0.50, p  = 0.62. 
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This suggests that the changes in BAT steps completed without rituals from POST to 1MFU 
were not significantly different for the two groups (model estimated difference in changes = -
0.27 steps). 
Calculations of effect size. Given these overall findings that changes in outcome 
measures were not significantly different for the two EXP groups, I next collapsed across 
exposure condition and examined the effect sizes of changes in the outcome measures from PRE 
to POST and PRE to 1MFU for the entire sample of participants who completed the study 
intervention (n = 26). Cohen’s d calculations for paired samples (Cohen, 1988) demonstrated 
large effect sizes for changes in Y-BOCS scores from PRE (M = 18. 73, SD = 4.75) to POST (M 
= 10.88, SD = 5.19; d = 1.58) and from PRE to 1MFU (M = 10.25, SD = 5.24; d = 1.70).  
Similarly, there were large effect sizes for changes in DOCS-UT scores from PRE (M = 7.50, SD 
= 2.45) to POST (M = 4.19, SD = 2.66; d = 1.29) and from PRE to 1MFU (M = 3.00, SD = 2.45; 
d = 1.84) as well as for changes in BAT mean SUDS from PRE (M = 39.72, SD = 22.81) to 
POST (M = 18.25, SD = 16.05; d = 1.09) and from PRE to 1MFU (M = 17.07, SD = 17.78; d = 
1.11) and changes in BAT steps completed without rituals from PRE (M = 2.42, SD = 1.58) to 
POST (M = 3.92, SD = 1.23; d = 1.06) and from PRE to 1MFU (M = 3.71, SD = 1.57; d = 0.82). 
Hypothesis 3. Finally, to examine the third hypothesis that in both conditions, average 
subjective (SUDS) and physiological (HR, SC) fear variability during exposure, but not 
habituation, would predict outcome for the target obsessional thought (i.e., POST and FU 
average together), I fit models including: (a) session number as a time varying predictor (re-
coded as 0 for POST and 1 for 1MFU), (b) pre-treatment scores and baseline fear measures (i.e., 
SUDS, SC, or HR measured during the 3 minute baseline period) as covariates, and (c) fear 
variability (ISD, AR) and within-session habituation (WSH) as the time-invariant predictors of 
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interest. Three separate models were run for the three types of fear measurements (i.e., SUDS, 
SC, and HR) for each outcome variable (i.e., Y-BOCS, DOCS-UT, BAT mean SUDS, BAT 
number of steps completed without performing a ritual).  
For the first outcome of interest, after controlling for PRE Y-BOCS scores and baseline 
SUDS, the ISD, AR, and WSH SUDS values did not significantly-predict Y-BOCS scores, ts(43) 
< 0.12, ps > .90. Similarly, after controlling for PRE Y-BOCS scores and baseline SCL, the ISD, 
AR, and WSH SCL values did not significantly-predict Y-BOCS scores, ts(39) < 1.86, ps > .07. 
Finally, after controlling for PRE Y-BOCS scores and baseline HR, the ISD, AR, and WSH HR 
values did not significantly-predict Y-BOCS scores, ts(42) < 1.58, ps > .12.  Null results of 
models with the other three outcomes (i.e., DOCS-UT, BAT mean SUDS, BAT steps completed 
without rituals) parallel those of the Y-BOCS, and thus the numeric results are not reported here. 
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DISCUSSION 
While preliminary research has demonstrated that varying the intensity of exposures (and 
associated anxious arousal; i.e., introducing “desirable difficulties”) enhances long-term 
outcomes relative to taking a gradual hierarchical approach for some anxiety-related problems 
(Lang & Craske, 2000; Rowe & Craske, 1998), no previous studies had empirically examined 
this question in the treatment of individuals with primary obsessions (i.e., about sex, immorality, 
religiosity, or harm). This is a clinically important question given: (a) predictions that patients 
with primary obsessions might especially benefit from exposures maximizing surprise and 
variability, since these types of thoughts often intrude abruptly without identifiable evoking 
stimuli (Lee & Kwon, 2003), and since (b) these individuals are particularly likely to have 
attenuated outcomes in response to ERP (e.g., Mataix-Cols et al., 2002; Williams et al., 2014). 
Accordingly, the current study sought to translate laboratory findings on inhibitory learning to 
exposure therapy for obsessions in order to ultimately improve ERP for this especially at-risk 
group. 
Results from the present study indicate that, in line with my first hypothesis, both gradual 
and random/variable exposure led to significant reductions in obsessional symptoms as measured 
by interview, self-report, and behavioral measures; with large effect sizes from pre- to post-
treatment and from pre-treatment to 1-month follow-up. More specifically, participants entered 
the present study with a mean Y-BOCS score of 19 (which is in the moderate range and above 
the clinical-cut off of 16) and completed treatment with a score of 11 (which is in the mild range), 
thus evidencing a 42% reduction in interview symptom scores (they similarly demonstrated a 
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44% reduction in self-report scores, 54% reduction in in vivo distress, as well as 62% 
improvement in behavioral assessments). These changes are in line with meta-analytic findings 
demonstrating the efficacy of ERP for OCD (Olatunji et al., 2012). Furthermore, despite the fact 
that individuals with primary obsessions have attenuated outcomes relative to other OCD 
symptom dimensions (e.g., Mataix-Cols et al., 2002; Williams et al., 2014), the present study 
demonstrates the potential effectiveness of exposure for obsessional thoughts; a problem once 
considered to be rare and “treatment-resistant” (Christensen et al., 1987).  
One main caveat to this finding, however, is that in order to maximize statistical power to 
test hypotheses about the different methods of delivering exposure, the present study did not 
employ a non-active psychological control group. Thus, the effects of symptom reduction might 
be inflated due to non-specific components of the interventions (e.g., talking to someone about 
the intrusive thought, psychoeducation about unacceptable thoughts, “placebo” effects due to 
participant expectations of their symptoms improving) or simply the passage of time (e.g., 
regression to the mean). However, numerous carefully conducted randomized controlled trials 
provide consistent evidence that ERP outperforms control treatments (e.g., relaxation) in the 
treatment of OCD (Olatunji et al., 2012), and wait-list-controlled studies have more specifically 
demonstrated efficacy for patients with primarily obsessional thoughts (Freeston et al., 1997). 
Nonetheless, future replication with viable psychological control groups (e.g., stress management 
skills) remains warranted. 
Next, despite overall significant reductions in symptoms from pre- to post-treatment, 
there were no significant differences in the degree of improvement (i.e., from pre- to post-
treatment or post-treatment to 1-month follow-up) when comparing the two exposure groups 
(EXP-G vs. EXP-V). These findings are contrary to my second hypothesis that individuals 
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receiving EXP-V would demonstrate superior outcomes at long-term (i.e., 1-month) follow-up 
relative to individuals receiving EXP-G. It is, however, in line with previous null findings from 
studies comparing gradual versus random/variable exposure for individuals with fears of 
contamination (Kircanski et al., 2012). There are a variety of potential reasons as to why this 
primary hypothesis was not supported, which also suggest directions for future research as I 
discuss in turn next.  
First, it is possible that conducting exposure from these two perspectives simply does not 
result in meaningful differences in treatment outcome. Many previous “horse race” studies that 
have attempted to compare ways of conducing or “framing” exposure have failed to produce 
significant differences in outcome (e.g., Abramowitz, Foa, & Franklin, 2003; Fedoroff & Taylor, 
2001; Resick, Nishith, Weaver, Astin, & Feuer, 2002; van Balkom et al., 1994; van Oppen et al., 
2010), suggesting that exposure therapy, no matter how it is packaged, is a highly effective 
treatment for addressing anxiety and fear. Accordingly, there may be ceiling effects that limit the 
detection of differential outcomes with this intervention (especially in the present non-treatment 
seeking sample, as will be discussed further below).  
Indeed, some of the studies mentioned previously that did demonstrate superior long-term 
outcomes for random/variable exposure (e.g., Rowe & Craske, 1998) used a constant exposure 
condition as a comparison group (i.e., conducting exposure repeatedly to the same stimulus; e.g., 
the same spider) instead of a gradual exposure condition (i.e., working up a fear hierarchy). 
While constant stimulus exposure is more of a true “control” condition (since only one feared 
stimulus is used), it is not truly testing the question of whether random/variable exposure is 
superior to treatment as usual (i.e., gradual, hierarchical exposure confronting increasingly 
challenging stimuli). Additionally, even studies that did use a gradual exposure group (e.g., Lang 
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& Craske, 2000) evidenced benefits for only certain outcome measures (e.g., reduced general 
anxiety) but not others (e.g., no differences on more specific measures of fear or physiological 
indices). Accordingly, it may be that as demonstrated by the null findings from the current and 
previous studies (e.g., Kircanski et al., 2012), as long as participants are confronting various 
levels of exposure difficulty, doing so either gradually or randomly is similarly effective. 
Furthermore, the fact that the current study did not find significant differences between 
exposure groups suggests that conducting exposures hierarchically (as is traditionally done) is 
sufficient, but not essential to produce significant improvement in obsessional fears. Specifically, 
the fact that there was no evidence that conducting exposure from a random/variable perspective 
is significantly better or worse than gradual exposure still speaks to the fact that it may not be 
harmful to conduct exposure utilizing this approach. Indeed, clinicians have anecdotally 
expressed concerns that patients might be “unwilling” or “unable” to engage in random/variable 
exposure therapy due to high levels of fear and avoidance. Prior to the present study, research 
had not yet investigated the extent to which a random/variable approach would be feasible and 
appear credible to participants with anxiety and obsessional thoughts. 
To this end, participants in the two exposure conditions in the present study expressed no 
differences in the credibility of the treatment rationales (i.e., fear reduction vs. fear tolerance), 
and both expected to see substantial reductions in their obsessional symptoms over the course of 
the intervention. Previous studies (Arch, Twohig, Deacon, Landy, & Bluett, 2015; England et al., 
2012) have also demonstrated that participants perceived rationales for exposure to be similarly 
credible when presented according to a variety of empirically-derived theoretical perspectives 
(and these rationales were seen as more credible compared to a basic definition of exposure 
without a theoretical explanation). Thus, it may be that as long as a convincing rationale is 
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provided, the specific theoretical explanation does not significantly impact exposure credibility. 
Furthermore, in the present study there were no differences in participant satisfaction with the 
exposure intervention they received, with comparable satisfaction levels to individuals receiving 
a standard package of ERP in a clinical setting (Tolin et al., 2011). These findings, therefore, 
provide preliminary evidence contrary to concerns that random/variable exposures would seem 
unappealing or even intolerable to those participating, at least in comparable samples with 
moderate distress. 
A second explanation for the present findings is that while varying the intensity of 
exposures enhances long-term outcomes relative to the conventional gradual hierarchical 
approach for some more circumscribed anxiety-related problems (e.g., phobias; Lang & Craske, 
2000; Rowe & Craske, 1998), differentiating between these two exposure approaches is 
practically challenging with more complex and heterogeneous problems such as obsessions/OCD. 
In contrast to phobias in which feared consequences are fairly immediate, specific, and triggered 
by known stimuli (e.g., “I’m scared the dog will bite me”), OCD requires adaptation of exposure 
to a variety of different feared consequences that vary from the immediate (e.g., “I won’t be able 
to stand the feeling of uncertainty about whether something bad has happened to my mother”), 
long-term (e.g., “Thinking about stabbing my spouse will cause me to lose control and commit 
this act one day”), and even unknowable (e.g., “What if I go to hell because I had a blasphemous 
thought?”). Fears also vary in terms of whether the unwanted consequences are directed toward 
oneself (e.g., “What if I suddenly “snap” and harm myself?”) versus toward others (“What if I 
blurt out an offensive derogatory comment?”). And, as previously mentioned, these types of 
obsessional fears often intrude abruptly without identifiable evoking stimuli (Lee & Kwon, 
2003). Hence, the many ways variability can be induced within the session becomes complex, 
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and individuals may not even be aware of all these possible factors and that they should be 
considered as ways to vary the exposure stimuli. 
Along these lines, one potentially important factor in the current study was that in 
generating the exposure “hierarchy” in the gradual exposure group, participants were not always 
adept at anticipating which exercises would truly generate low, moderate, and high levels of 
anxiety. More specifically, they were often surprised by how challenging the imaginal exposure 
scripts were relative to other tasks (e.g., news articles or videos) since the anxiety-provoking 
material generated as part of these scripts was especially personal, vivid, and targeted to their 
own feared consequences. Thus, exposure from a gradual perspective appeared to be more 
“variable” than expected, such that the two exposure conditions might have been more alike than 
was desirable. This is in contrast to previous research with individuals with contamination fears 
in which low, medium, and high intensity exposure items evoked increasingly elevated levels of 
subjective distress (Kircanski et al., 2012). While this is a methodological challenge in the field 
of OCD research relative to other anxiety disorders, it is also a problem that is inherent to 
studying the phenomenon, and thus will be a continued challenge for future research on 
inhibitory learning applications to OCD. 
Relatedly, BATs for intrusive thoughts are less straightforward than BATs for other more 
circumscribed fears such as spiders (Olatunji, Huijding, de Jong, & Smits, 2011; Woody, 
McLean, & Klassen, 2005), public-speaking (Amir, Weber, Beard, Bomyea, & Taylor, 2008; 
Culver et al., 2012), and contamination (Cougle, Wolitzky-Taylor, Lee, & Telch, 2007; Najmi, 
Tobin, & Amir, 2012) in which there typically is a series of rank ordered behavioral steps each 
increasingly difficult in magnitude (e.g., “Hold the tarantula in your hands”). Furthermore, 
rituals and other escape behaviors (e.g., hand washing, not holding the tarantula for the specified 
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duration of time) in the course of such BATs is easier to quantify. In contrast, the present BAT 
relied upon participants’ self-report of their own mental rituals (e.g., analyzing, neutralizing) in 
order to determine whether a step was fully completed. Thus, the relative ease with which mental 
rituals can be enacted without the evaluator’s awareness presents methodological challenges for 
behavioral assessment of primary obsessions. Accordingly, despite the fact that the items 
included in the BAT for the current study were effective in generating anxiety (and were 
correlated with OC symptom severity), there may have been a ceiling effect in terms of the 
number of BAT steps participants could complete (and even the number of steps completed 
without rituals). Given the heterogeneity of fears in OCD, future studies may wish to utilize an 
idiographic approach to determining potential BAT items in order to generate more possible 
steps for future research (Steketee et al., 1996). 
Third, it may be that the differential impact of gradual versus variable exposure on 
obsessional symptoms in a pre-clinical (i.e., analog) sample is different than the results would be 
in a clinical, treatment-seeking sample. This explanation is tempered by the fact that we 
successfully recruited a sample of participants who were moderately distressed by their intrusive 
thought. Specifically, the mean Y-BOCS score in the current study was slightly above the 
clinical cut-off (Goodman et al., 1989a, 1989b) and the DOCS-UT score was elevated relative to 
a group of unscreened undergraduate students (Abramowitz et al., 2010). Furthermore, the study 
of non-clinical intrusive thoughts has the potential to inform the mechanisms involved in the 
treatment of clinically severe obsessions since non-clinical and clinical obsessions have similar 
content (e.g., Belloch et al., 2004; Radomsky et al., 2014), and are associated with the same 
developmental and maintenance factors (Abramowitz et al., 2014). Furthermore, as has been 
discussed by previous researchers (Vervliet, Craske, & Hermans, 2013), clinical analog (or “pre-
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clinical”) studies that target extinction of pre-existing fears in anxious individuals are useful for 
testing the application of fundamental scientific principles to real world fears (to be later 
translated to clinical efficacy studies). 
Nonetheless, there are differences between pre-clinical and clinical samples in the 
implementation of exposure that may have implications for future research. For instance, it may 
be that the moderate level of distress participants in the current study experienced as a result of 
their intrusive thought was not sufficiently impairing for them to fully invest high levels of 
anxiety in certain exposure exercises. In contrast, those with clinical levels of anxiety may be 
highly motivated to tackle exercises aimed to improve their quality of life. Indeed, in the present 
study there appeared to be individual differences in terms of participants’ effort levels in 
ensuring exposures were as anxiety provoking (and thus as useful) as possible. For instance, 
some participants appeared to be more engaged in the script-writing process such that they used 
more vivid descriptions of their feared consequences. Future research, therefore, may wish to 
code information such as the vividness of the exposure scripts as rated by either participants (e.g., 
on a scale from 0 = Cannot see the image at all to 100 = Very vivid, feels as if it were happening 
now; Rauch, Foa, Furr, & Filip, 2004), therapists, or independent evaluators in order to explore 
the extent to which these ratings may predict outcome.  
Moreover, the current study examined the effectiveness of an intentionally brief and 
specific analog treatment (i.e., 4 sessions) for one target obsessional thought. While this design 
aimed to maximize the study’s internal validity (without sacrificing clinical utility), future 
studies could examine the introduction of variability to a more complete package of ERP. For 
instance, a relevant question would be whether outcome is enhanced by not only varying levels 
of exposure intensity for one target thought (as in the current study), but also by varying the 
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target obsessional thought itself for individuals with more than one obsessional fear (e.g., related 
to violence/harm and also symmetry/exactness). Additionally, the current study did not involve 
the assignment of any homework exercises between exposure sessions (as is traditionally done in 
clinical settings), and future investigations could see whether encouraging participants to also 
incorporate variability into their exposure practice between sessions (i.e., varying exposure 
intensity in different environmental contexts) would demonstrate any effects. In summary, 
therefore, future studies should recruit samples with clinical levels of obsessional symptoms and 
administer more comprehensive treatments in order to better understand how these inhibitory 
learning models may translate to treatment-seeking individuals. 
A fourth potential explanation for the lack of group differences is that the present study 
was underpowered. Based on previous research (Lang & Craske, 2000; Rowe & Craske, 1998), 
with a sample size of 15 per group, the present study has estimated power of 0.6 to detect 
significant group differences at the .05 level. However, from examining the mean differences in 
outcomes, it appears that even if sample size were increased, the magnitude of the group 
differences is so minimal to as not be clinically meaningful (e.g., a difference of 1-3 points on 
the Y-BOCS between the two groups at post-treatment and follow-up). Similarly, it could be that 
a 1-month follow-up period was not sufficiently long to be able to capture differential return of 
fear among the two exposure groups.  The present study’s hypotheses were that individuals in the 
gradual exposure group would perform well at the end of treatment, but be vulnerable to return 
of fear during the follow-up period. However, neither group experienced significant return of 
fear as measured by interview, self-report, or behavioral measures over the course of the 1-month 
follow-up period. At 1-month follow-up, however, participants in the EXP-G condition 
evidenced a 1.33 point (non-significant) increase in their Y-BOCS scores, whereas individuals in 
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the EXP-V group evidenced a (non-significant) 1.43 point decrease; thus, it could be that at a 
later follow-up period these scores might continue to diverge. Accordingly, future research 
should extend the assessment period in order to monitor return of fear for a longer period of time. 
Fifth, it may be that the effect of differing exposure conditions is more subtle or nuanced 
than was measured in the current study. For instance, rather than having an impact on global 
symptom outcomes, it may be that the framing and implementation of exposure therapy 
influences other cognitive measures regarding beliefs about exposure. For example, several 
participants in the gradual exposure condition anecdotally made comments during debriefing 
following the high intensity exposures (i.e., session 4) that although the exposures went better 
than expected, they “never” could have done these exercises at the first session. Thus, it appears 
that confronting exposures gradually perpetuates beliefs about one’s self-efficacy to approach 
feared stimuli (i.e., that one can only confront more challenging exposure tasks after achieving 
success during “easier” ones) that may warrant future study. Specifically, measures have been 
developed in previous research to examine participant perceived self-efficacy over the course of 
exposure therapy (e.g., using an in vivo scale from 0-100 during exposures or BATs; Kircanski et 
al., 2012). Such measures could compare changes in fear-related self-efficacy in gradual vs. 
random/variable exposure conditions. 
Furthermore, of the participants that withdrew over the course of the exposure 
intervention, all four were from the gradual exposure group. While two of the participants named 
solely logistical reasons for leaving the study (i.e., the time commitment, difficulty getting to the 
UNC campus), the other two directly cited high levels of provoked anxiety as a reason for 
leaving the study (e.g., mentioning the “emotional stress” of the tasks) and both dropped after the 
first (i.e., low intensity) exposure session and before the second (i.e., moderate intensity) session. 
  55 
With such a small number of participants who dropped from the study, it is not possible to make 
decisive interpretations of this information. However, these drops may potentially be due to 
treatment assignment (i.e., they are not “missing at random”), and had these participants 
continued in the study they may have done worse by post and follow-up than those who 
continued on in treatment. Accordingly, future studies should continue to assess participants who 
withdraw from the exposure interventions over the course of the follow-up period (to the extent 
that it is possible) in order to track possible return of fear. 
Another related empirical question for future study is whether conducting exposure from 
a gradual perspective perpetuates “fear of fear” (relative to random/variable exposure) such that 
anxiety in anticipation of more difficult exposure sessions (e.g., moving from “mild” to 
“moderate” tasks) leads participants to discontinue treatment. Indeed, the challenging and 
anxiety-provoking nature of exposure-based techniques contributes to the fact that between 11-
31% of patients drop out prematurely (e.g., Mancebo, Eisen, Sibrava, Dyck, & Rasmussen, 2011; 
Simpson et al., 2008; Tolin et al., 2007). Given the effectiveness of exposure, developing ways 
to make these techniques more tolerable and reduce patient dropout, while not compromising 
therapeutic integrity, is an important next step in OCD treatment research. For instance, an 
ecological momentary assessment approach could be utilized in which participants are asked 
their levels of anticipatory anxiety in real time prior to each exposure session (e.g., the day 
before, a few hours before, etc.) in order to examine whether these in vivo measures predict 
whether a participant will skip a session or discontinue the intervention.  
Finally, there may be important moderators of treatment outcome that the current study 
was underpowered to measure that may differentially impact the effectiveness of these exposure 
treatment frameworks. For example, it may be that individuals with obsessions who demonstrate 
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high intolerance of uncertainty (IU) would particularly benefit from interventions that maximize 
variability and uncertainty during exposure. Several participants in the variable exposure group 
mentioned that while they found the uncertainty of not knowing which exposure exercise was 
coming next to be anxiety-provoking, that this was useful given how central uncertainty was to 
their intrusive thought. Thus, conducting exposure exercises randomly may serve to maximize 
levels of uncertainty during exposure therapy to confront this aversive (but ubiquitous) 
experience. Similarly, those with elevated anxiety sensitivity  (i.e., the tendency to misconstrue 
benign sensations of anxious arousal as dangerous; or the “fear of fear”; Taylor et al., 2007)  
might benefit from variable exposure conditions in which their anxiety levels are rapidly shifting 
and changing. Future research utilizing larger sample sizes should examine these extent to which 
these baseline, trait-level variables predict who will benefit most from each exposure treatment. 
Accordingly, it would be advantageous for exposure therapists working with individuals with 
anxiety disorders to be able to “prescribe” different ways of conducting exposure (i.e., gradual vs. 
random/variable approaches) depending on their patients’ levels of these constructs pre-treatment. 
If future research were able to demonstrate a clinical benefit to conducting exposure from 
a random/variable perspective, this could impact the ways in which exposure therapy is delivered 
in clinical settings. First, as previously alluded to, it would be important to demonstrate 
feasibility of implementation in clinical populations. For instance, one potential adaptation of the 
methods in the present study would be for patient and therapist to agree in advance on a subset of 
exposure items to be randomly selected if the patient were not yet willing to confront certain 
items on the list. Furthermore, the fact that that there is no evidence in the present study of 
differential outcomes when conducting exposures out of order versus proceeding in a graduated 
fashion, suggests that exposures could also be selected based on life interference (i.e., values and 
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goals for treatment). For example, a new mother with unacceptable intrusive thoughts that one 
day she might “snap” and smother her newborn baby, may decide that she wants to engage in an 
exposure where she puts the baby down for a nap (i.e., with pillows nearby; SUDS = 85) before 
conducting later imaginal exposure to related words (e.g., pillow, smother, child; SUDS = 50) or 
news stories (e.g., about infamous criminal cases of mothers harming their children; SUDS = 70), 
so that she can spend time with her new baby again as soon as possible. Conducting exposures in 
this manner allows patient goals and values to drive the progression of treatment, introduces 
desirable difficulties, fosters fear tolerance, and does not over-rely on habituation of anxiety. 
Additionally, an important area for future study would be to understand the mechanisms 
by which random/variable exposure leads to improvements in treatment outcome. For example, 
although a component of exposure debriefing for those in the variable exposure condition in the 
present study involved discussing participants’ level of surprise during the exposure exercises, 
future studies could empirically measure the degree of participant surprise regarding the 
discrepancy between their predicted and actual exposure task outcomes (e.g., on a scale from 0 = 
no surprise to 100 = extreme surprise). Given the theoretical rationale that introducing elements 
of variability maximizes surprise and provides patients with repeated opportunities for corrective 
learning (Rescorla & Wagner, 1972; Wagner & Rescorla, 1972), measuring participant surprise 
levels would allow for questions of meditation (i.e., does the degree of participant surprise 
mediate reductions in obsessional symptom severity in the variable exposure group).  
Similarly, BAT measurement at follow-up could be improved by including a 
generalization test in order to measure the extent to which learned skills extend to novel stimuli 
(e.g., Bjork & Bjork, 2006; Rowe & Craske, 1998; Schmidt & Bjork, 1992). Specifically, 
participants could be asked to confront a novel “step” in the post-treatment and follow-up BAT 
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(i.e., a “surprise” item; e.g., putting the notecard in their pocket, visualizing and verbalizing a 
feared scenario related to their intrusive thought; repeatedly writing the phrase “I hope and pray 
[the thought] comes true”). It may be that if the random/variable exposure condition allows 
individuals to better adapt to conditions of exposure that are shifting and changing, they may be 
more likely to complete these novel steps without performing a ritual.   
A secondary question in the current study was the extent to which measures of 
habituation and fear variability predict outcome following the exposure interventions. The results 
of this study add to a growing body of literature that within-session habituation is not associated 
with clinical outcomes (Baker et al., 2010; Jaycox et al., 1998; Kozak et al., 1988; Meuret et al., 
2012). Since decline in anxiety during exposure may occur, but is not necessary for optimal 
long-term outcome, therapists in real-world clinical settings may be over-relying on habituation 
as an indicator of patient improvement. Second, contrary to hypotheses, average subjective 
(SUDS) and physiological (HR, SC) fear variability during exposure did not predict outcome for 
the target obsessional thought. These findings are in contrast to previous studies suggesting that 
variability of subjective fear responding during exposure predicts superior long-term outcomes 
(i.e., lower anticipatory and self-reported fear at follow-up testing) in samples fearful of public 
speaking (Culver et al., 2012) and contamination (Kircanski et al., 2012). However, these 
previous results did not extend to variability in psychophysiological responses during exposure, 
suggesting that more research is needed.  
In particular, one area for future research based on these discrepant findings would be to 
further examine the disconnect between self-reported and physiological indices of anxious 
arousal since longstanding work suggests that there is often a “desynchrony” (Craske et al., 
2012) between subjective and physiological measures (Craske, Sanderson, & Barlow, 1987; 
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Gauthier & Marshall, 1977; Lande, 1982). Frequently, participants in the present study reported 
an increase in subjective distress during exposures, whereas their heart rate and skin conductance 
measures would remain level (and vice versa). Accordingly, it would be useful to know the 
extent to which this discrepancy is meaningful for outcome (i.e., whether there are differences in 
exposure outcome for individuals who experience higher subjective distress with lower 
physiological reactivity or vice versa) versus whether the difference is due to imperfect 
measurement (e.g., artifactual noise in physiological measurement).  
Additionally, it may also be that subjective fear variability has greater importance for the 
outcomes of exposure for fears of public speaking and contamination, but does not apply to the 
treatment of obsessions. For instance it could be that precisely because individuals with primary 
obsessions cannot reach absolute certainty about their feared consequences and frequently 
experience fear cues that intrude abruptly without known triggers, that there is not much room 
for improvement in terms of maximizing uncertainty and variability. Future research examining 
variability of fear in exposure across various presenting problems could directly address this 
empirical question. Similarly, an additional avenue for future research would be to better 
understand individual-level predictors of fear variability during exposure. For instance, it may be 
that factors such as exposure credibility or baseline levels of distress tolerance (i.e., one’s 
willingness or ability to experience, tolerate, and function in the context of 
emotional/psychological distress; Simons & Gaher, 2005) allow individuals to fully engage in 
the difficult tasks (thus maximizing their own fear variability). If these predictors could be 
identified, it may be that directly targeting such constructs could result in heighted fear 
variability and improved subsequent treatment outcomes. 
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Conclusions 
 In summary, the current study sought to translate laboratory research on inhibitory 
learning to the use of ERP for primary obsessions (i.e., sexual, violent, and immoral/religious 
content), with the ultimate aim of maximizing outcome and reducing the need for follow-up 
services for this group of at-risk patients. Specifically, I compared two frameworks for 
conducting exposure therapy: (a) gradual exposure (EXP-G) emphasizing fear reduction, and (b) 
variable exposure (EXP-V), maximizing variability in exposure intensity. Methodological 
strengths of the study included: (a) the use of objective biological measures of therapeutic 
mechanisms and processes (i.e., skin conductance and heart rate) for more complete 
understanding of fear learning, and (b) experimenter-aided ideographic exposure stimuli 
selection and delivery of a theoretical rationale for EXP to enhance clinical utility. 
Both EXP interventions were associated with significant decreases in interview, self-
report, and behavioral measures of fear at POST, with no significant differences in PRE/POST 
between the two groups. Furthermore, there was no significant return of fear for either group 
from POST to 1MFU. Thus, the random/variable method of exposure warrants future study to 
better understand the implications of this novel approach (e.g., mechanisms of change, potential 
moderators of outcome, etc.), and how the findings extend to studies with longer-term follow-up 
periods or utilizing clinical samples. Subjective (SUDS) and physiological (HR and SC) indices 
of fear variability did not predict treatment outcomes, which is in contrast to previous studies 
suggesting benefits of variability in subjective fear level during exposure for other anxiety-
related problems. Investigations of the desynchrony between subjective and physiological 
measures of fear may be an area for future research. 
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TABLE 1. Administration schedule for study measures 
 
 Session 1 
PRE Session 2 Session 3 
Session 4 
POST 1MFU 
MINI X     
Y-BOCS X   X X 
DOCS-UT X X X X X 
BDI-II X   X X 
BAT X   X X 
CEQ X     
CSQ    X  
 
 
Note. MINI = Mini-International Neuropsychiatric Interview; Y-BOCS = Yale-Brown Obsessive 
Compulsive Scale; DOCS-UT = Dimensional Obsessive-Compulsive Scale–Unacceptable Thoughts; 
BDI-II = Beck Depression Inventory; BAT = Behavioral Approach Test; CEQ = Credibility/Expectancy 
Questionnaire; CSQ = Client Satisfaction Questionnaire.  
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TABLE 2. Session-by-session components for the two EXP conditions 
 
 
Session EXP-G EXP-V 
1 • Assessment and identification of the target obsessional thought 
• Present the model of obsessions and rationale for EXP (from the appropriate perspective) 
• Generate the exposure list 
2 • Experimenter-supervised exposure to 3 
“mild” stimuli (8 min each)  • Experimenter-supervised exposure to 3 randomly selected stimuli of varying intensity (8 min each) 
3 • Experimenter-supervised exposure to 3 
“moderate” stimuli (8 min each) 
• Experimenter-supervised exposure to 3 
randomly selected stimuli of varying 
intensity (8 min each) 
4 • Experimenter-supervised exposure to 3 
“intense” stimuli (8 min each) 
• Discussion of relapse-prevention 
• Experimenter-supervised exposure to 3 
randomly selected stimuli of varying 
intensity (8 min each) 
• Discussion of relapse-prevention 
 
Note.  EXP-G = Gradual exposure condition; EXP-V = variable exposure condition.  
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TABLE 3. Sample exposure list 
 
Obsession: Unwanted thought of stabbing spouse  
Item Intensity 
1. The word “stab” Mild 
2. Hold a pen and imagine stabbing spouse Mild 
3. Image of garden shears Mild 
4. Image of a kitchen knife Moderate 
5. Hold scissors and imagine stabbing spouse Moderate 
6. Image of someone holding a knife in a stabbing motion Moderate 
7. Write a script about stabbing husband High 
8. Read news stories of stabbings High 
9. Write husband’s obituary High 
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TABLE 4. Socio-demographic characteristics of the sample by EXP group 
 
 Total Sample 
N = 30 
EXP-G 
n = 14 
EXP-V 
n = 16 
Test for difference 
Age (years), M (SD) 22.97 (6.17) 23.79 (5.79) 22.25 (6.59) t(28) = 0.67, p = .51 
Gender, % female (n) 73.3% (22) 64.3% (9) 81.3% (13) F2(2) = 1.13, p = .57 
Race, % (n) 1    F2(1) = 0.26, p = .87 
     African American or Black 6.7% (2) 0.0% (0) 12.5% (2)  
     White or Caucasian 70.0% (21) 71.4% (10) 68.8% (11)  
     Asian 10.0% (3) 7.1% (1) 12.5% (2)  
     Biracial or Multiracial 13.3% (4) 21.4 (3) 6.3% (1)  
Years of Education, M (SD) 15.20 (3.63) 16.21 (3.79) 14.31 (3.36) t(28) = 1.46, p = .16 
 
1 Chi-square for participant race compares percentages of white vs. non-white participants due to small 
sample size of certain racial groups (ns < 5).
  
 
TABLE 5. Descriptive statistics for clinical measures by EXP group and time point 
 
 EXP-G Group  EXP-V Group 
 PRE 
n = 14 
POST 
n = 10 
1MFU1 
n = 9 
 PRE 
n = 16 
POST 
n = 16 
1MFU 
n = 15 
Y-BOCS  18.29 (6.32) 10.20 (3.65) 11.33 (2.40)  18.44 (3.29) 11.31 (6.03) 9.60 (6.37) 
DOCS-UT 7.21 (2.64) 4.70 (2.83) 3.78 (1.92)  7.19 (2.40) 3.88 (2.58) 2.53 (2.67) 
BDI-II 8.50 (6.75) 6.44 (4.39) 5.89 (4.29)  12.81 (7.71) 12.13 (8.28) 8.07 (6.84) 
BAT        
 37.43 (20.83) 12.96 (10.91) 10.46 (9.67)  45.85 (23.13) 21.56 (18.10) 21.03 (20.53) 
     Steps completed without 
          rituals (0-5) 2.43 (1.56) 4.20 (1.23) 3.89 (1.27) 
 2.25 (1.53) 3.75 (1.24) 3.60 (1.77) 
CEQ        
     Credibility 18.86 (4.24)    17.88 (3.70)   
     Expectancy2 0.71 (3.35)    -0.62 (2.13)   
CSQ  25.10 (3.98)    25.62 (4.95)  
 
Note. Y-BOCS = Yale-Brown Obsessive Compulsive Scale; DOCS-UT = Dimensional Obsessive-Compulsive Scale–Unacceptable Thoughts; 
BDI-II = Beck Depression Inventory; BAT = Behavioral Approach Test; SUDS = Subjective Units of Distress Scale; CEQ = 
Credibility/Expectancy Questionnaire; CSQ = Client Satisfaction Questionnaire. 
 
1 Two participants (one from the EXP-G and one from the EXP-V group were in the middle of their 1-month follow-up period at the time of this 
defense). 
 
2 Expectancy subscale scores have been transformed to z-scores
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TABLE 6. Associations among baseline interview, self-report, and behavioral study measures (N 
= 30) 
 
Measure 
 
1 2 3 4 5 
1. Y-BOCS 
 
___ .63** .29 .09 -.37* 
2. DOCS-UT 
 
 ___ .22 .09 -.29 
3. BDI-II 
 
  ___ .21 -.33 
4. BAT mean SUDS  
 
   ___ -.51** 
5. BAT steps completed 
without rituals 
 
    ___ 
 
Note. * p < .05; **p < .01;  Y-BOCS = Yale-Brown Obsessive Compulsive Scale; DOCS-UT = 
Dimensional Obsessive-Compulsive Scale–Unacceptable Thoughts; BDI-II = Beck Depression Inventory; 
BAT = Behavioral Approach Test; SUDS = Subjective Units of Distress Scale 
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TABLE 7. Descriptive statistics for exposure process variables for those who completed the 
exposure intervention. 
 
 M (SD) 
Baseline measures  
     Mean SUDS 6.37 (6.49) 
     Mean SCL 4.23 (2.20) 
     Mean HR 84.57 (8.21) 
EXP subjective measures (N = 26)  
     Mean SUDS 27.05 (13.78) 
     ISD SUDS 10.60 (4.24) 
     Peak SUDS 46.37 (17.10) 
     Final SUDS 26.50 (16.65) 
     WSH SUDS 19.87 (10.58) 
     AR SUDS 0.57 (0.23) 
EXP skin conductance measures (N = 24)1  
     Mean SCL 5.25 (2.47) 
     ISD SCL 0.69 (0.29) 
     Peak SCL 7.71 (3.09) 
     Final SCL 5.41 (2.53) 
     WSH SCL 2.29 (1.39) 
     AR SCL 0.87 (0.08) 
EXP heart rate measures (N = 25)  
     Mean HR 79.61 (7.63) 
     ISD HR 4.34 (0.94) 
     Peak HR 103.49 (7.44) 
     Final HR 78.68 (7.70) 
     WSH HR 24.81 (6.40) 
     AR HR 0.51 (0.13) 
 
Note. SUDS = Subjective Units of Distress Scale; ISD = intra-individual standard deviation; WSH = 
within-session habituation; AR = autoregressive parameter; SCL = skin conductance level; HR = heart 
rate.  
 
1 Abnormal SC data was removed for 2 participants and HR data was removed for one participant. 
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